Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	mRNA binding	CIRBP NANOS3 HNRNPA0 LARP1 ALYREF LSM14A NCL TAF15 SERBP1 FUS FMR1 MBD2 FXR2 CHTOP HNRNPR	6.52e-14	694	33	15	GO:0003729
GeneOntologyMolecularFunction	mRNA 3'-UTR binding	CIRBP HNRNPA0 LARP1 TAF15 SERBP1 FUS FMR1 FXR2 HNRNPR	4.66e-10	276	33	9	GO:0003730
GeneOntologyMolecularFunction	histone H2AQ104 methyltransferase activity	FBLL1 FBL	2.65e-06	2	33	2	GO:1990259
GeneOntologyMolecularFunction	protein-glutamine N-methyltransferase activity	FBLL1 FBL	7.94e-06	3	33	2	GO:0036009
GeneOntologyMolecularFunction	mRNA 5'-UTR binding	LARP1 NCL FMR1	9.23e-06	25	33	3	GO:0048027
GeneOntologyMolecularFunction	histone H2A methyltransferase activity	FBLL1 FBL	1.59e-05	4	33	2	GO:0140940
GeneOntologyMolecularFunction	protein methyltransferase activity	FAM98A FBLL1 KMT2B FBL	2.44e-05	103	33	4	GO:0008276
GeneOntologyMolecularFunction	translation regulator activity	CIRBP LARP1 SERBP1 FMR1 FXR2 PAIP1	7.68e-05	443	33	6	GO:0045182
GeneOntologyMolecularFunction	siRNA binding	FMR1 MBD2	1.73e-04	12	33	2	GO:0035197
GeneOntologyMolecularFunction	histone methyltransferase activity	FBLL1 KMT2B FBL	2.18e-04	71	33	3	GO:0042054
GeneOntologyMolecularFunction	RNA 7-methylguanosine cap binding	LARP1 FMR1	2.38e-04	14	33	2	GO:0000340
GeneOntologyMolecularFunction	translation activator activity	LARP1 PAIP1	2.74e-04	15	33	2	GO:0008494
GeneOntologyMolecularFunction	methyltransferase activity	FAM98A FBLL1 KMT2B FBL	4.04e-04	213	33	4	GO:0008168
GeneOntologyMolecularFunction	transferase activity, transferring one-carbon groups	FAM98A FBLL1 KMT2B FBL	4.89e-04	224	33	4	GO:0016741
GeneOntologyMolecularFunction	RNA cap binding	LARP1 FMR1	5.45e-04	21	33	2	GO:0000339
GeneOntologyMolecularFunction	N-methyltransferase activity	FBLL1 KMT2B FBL	6.87e-04	105	33	3	GO:0008170
GeneOntologyMolecularFunction	protein-RNA adaptor activity	ALYREF FMR1	7.15e-04	24	33	2	GO:0140517
GeneOntologyMolecularFunction	rRNA methyltransferase activity	FBLL1 FBL	7.15e-04	24	33	2	GO:0008649
GeneOntologyMolecularFunction	catalytic activity, acting on a rRNA	FBLL1 FBL	7.76e-04	25	33	2	GO:0140102
GeneOntologyMolecularFunction	single-stranded RNA binding	CIRBP LSM14A FMR1	8.08e-04	111	33	3	GO:0003727
GeneOntologyMolecularFunction	ribosome binding	LARP1 SERBP1 FMR1	1.01e-03	120	33	3	GO:0043022
GeneOntologyMolecularFunction	methyl-CpG binding	MBD2 CHTOP	1.20e-03	31	33	2	GO:0008327
GeneOntologyMolecularFunction	poly(U) RNA binding	CIRBP FMR1	1.44e-03	34	33	2	GO:0008266
GeneOntologyMolecularFunction	poly-pyrimidine tract binding	CIRBP FMR1	1.89e-03	39	33	2	GO:0008187
GeneOntologyMolecularFunction	translation initiation factor binding	LARP1 FMR1	1.89e-03	39	33	2	GO:0031369
GeneOntologyMolecularFunction	molecular condensate scaffold activity	FUS FMR1	2.19e-03	42	33	2	GO:0140693
GeneOntologyMolecularFunction	S-adenosylmethionine-dependent methyltransferase activity	FBLL1 KMT2B FBL	2.83e-03	172	33	3	GO:0008757
GeneOntologyMolecularFunction	ribonucleoprotein complex binding	LARP1 SERBP1 FMR1	4.70e-03	206	33	3	GO:0043021
GeneOntologyMolecularFunction	regulatory RNA binding	FMR1 MBD2	4.71e-03	62	33	2	GO:0061980
GeneOntologyMolecularFunction	RNA methyltransferase activity	FBLL1 FBL	5.48e-03	67	33	2	GO:0008173
GeneOntologyMolecularFunction	histone modifying activity	FBLL1 KMT2B FBL	6.30e-03	229	33	3	GO:0140993
GeneOntologyMolecularFunction	double-stranded RNA binding	LSM14A ILF2	7.35e-03	78	33	2	GO:0003725
GeneOntologyMolecularFunction	rRNA binding	CIRBP NCL	7.54e-03	79	33	2	GO:0019843
GeneOntologyMolecularFunction	translation regulator activity, nucleic acid binding	LARP1 PAIP1	1.47e-02	112	33	2	GO:0090079
GeneOntologyMolecularFunction	translation repressor activity	CIRBP SERBP1 FMR1	1.75e-02	334	33	3	GO:0030371
GeneOntologyMolecularFunction	single-stranded DNA binding	ALYREF NCL	2.06e-02	134	33	2	GO:0003697
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	CIRBP NANOS3 HNRNPA0 LARP1 TRA2A NCL TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	6.74e-14	443	33	13	GO:1903311
GeneOntologyBiologicalProcess	mRNA metabolic process	CIRBP NANOS3 HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL TAF15 SERBP1 FUS FMR1 RBM27 FXR2 PAIP1 HNRNPR	1.17e-13	917	33	16	GO:0016071
GeneOntologyBiologicalProcess	regulation of mRNA stability	CIRBP NANOS3 HNRNPA0 LARP1 TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	5.57e-13	292	33	11	GO:0043488
GeneOntologyBiologicalProcess	regulation of RNA stability	CIRBP NANOS3 HNRNPA0 LARP1 TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	9.95e-13	308	33	11	GO:0043487
GeneOntologyBiologicalProcess	regulation of mRNA catabolic process	CIRBP NANOS3 HNRNPA0 LARP1 TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	1.03e-12	309	33	11	GO:0061013
GeneOntologyBiologicalProcess	mRNA catabolic process	CIRBP NANOS3 HNRNPA0 LARP1 TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	7.92e-12	373	33	11	GO:0006402
GeneOntologyBiologicalProcess	RNA catabolic process	CIRBP NANOS3 HNRNPA0 LARP1 TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	3.83e-11	432	33	11	GO:0006401
GeneOntologyBiologicalProcess	nucleic acid catabolic process	CIRBP NANOS3 HNRNPA0 LARP1 TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	8.22e-11	464	33	11	GO:0141188
GeneOntologyBiologicalProcess	mRNA stabilization	CIRBP HNRNPA0 LARP1 TAF15 FUS PAIP1	2.27e-09	77	33	6	GO:0048255
GeneOntologyBiologicalProcess	RNA processing	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL FAM98A TAF15 FUS FBLL1 FMR1 GAR1 RBM27 FBL HNRNPR	2.33e-09	1500	33	15	GO:0006396
GeneOntologyBiologicalProcess	RNA splicing	CIRBP TRA2A U2AF1 ALYREF NCL FAM98A TAF15 FUS FMR1 HNRNPR	3.74e-09	502	33	10	GO:0008380
GeneOntologyBiologicalProcess	negative regulation of mRNA catabolic process	CIRBP HNRNPA0 LARP1 TAF15 FUS PAIP1	4.78e-09	87	33	6	GO:1902373
GeneOntologyBiologicalProcess	RNA stabilization	CIRBP HNRNPA0 LARP1 TAF15 FUS PAIP1	5.12e-09	88	33	6	GO:0043489
GeneOntologyBiologicalProcess	nucleobase-containing compound catabolic process	CIRBP NANOS3 HNRNPA0 LARP1 TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	5.87e-09	696	33	11	GO:0034655
GeneOntologyBiologicalProcess	post-transcriptional regulation of gene expression	CIRBP NANOS3 HNRNPA0 LARP1 LSM14A NCL TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	9.77e-09	1153	33	13	GO:0010608
GeneOntologyBiologicalProcess	negative regulation of RNA catabolic process	CIRBP HNRNPA0 LARP1 TAF15 FUS PAIP1	1.18e-08	101	33	6	GO:1902369
GeneOntologyBiologicalProcess	negative regulation of mRNA metabolic process	CIRBP HNRNPA0 LARP1 TAF15 FUS PAIP1	2.58e-08	115	33	6	GO:1903312
GeneOntologyBiologicalProcess	regulation of translation	CIRBP NANOS3 LARP1 LSM14A NCL SERBP1 FMR1 FXR2 PAIP1	5.58e-08	494	33	9	GO:0006417
GeneOntologyBiologicalProcess	negative regulation of translation	CIRBP NANOS3 LARP1 LSM14A NCL SERBP1 FMR1	6.53e-08	230	33	7	GO:0017148
GeneOntologyBiologicalProcess	mRNA processing	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL FMR1 RBM27 HNRNPR	1.41e-07	551	33	9	GO:0006397
GeneOntologyBiologicalProcess	positive regulation of mRNA metabolic process	CIRBP NANOS3 TRA2A NCL FXR2 PAIP1 HNRNPR	1.47e-07	259	33	7	GO:1903313
GeneOntologyBiologicalProcess	stress granule assembly	CIRBP LSM14A FMR1 UBAP2L	3.08e-07	36	33	4	GO:0034063
GeneOntologyBiologicalProcess	regulation of catabolic process	CIRBP NANOS3 HNRNPA0 LARP1 TAF15 SERBP1 FUS FMR1 FXR2 PAIP1 HNRNPR	2.21e-06	1252	33	11	GO:0009894
GeneOntologyBiologicalProcess	positive regulation of translation	CIRBP LARP1 FMR1 FXR2 PAIP1	3.96e-06	151	33	5	GO:0045727
GeneOntologyBiologicalProcess	translation	CIRBP NANOS3 LARP1 LSM14A NCL SERBP1 FMR1 FXR2 PAIP1	4.03e-06	824	33	9	GO:0006412
GeneOntologyBiologicalProcess	regulation of translation at presynapse	FMR1 FXR2	7.44e-06	3	33	2	GO:0140244
GeneOntologyBiologicalProcess	box C/D sno(s)RNA metabolic process	FBLL1 FBL	7.44e-06	3	33	2	GO:0033967
GeneOntologyBiologicalProcess	box C/D sno(s)RNA processing	FBLL1 FBL	7.44e-06	3	33	2	GO:0034963
GeneOntologyBiologicalProcess	regulation of translation at presynapse, modulating synaptic transmission	FMR1 FXR2	7.44e-06	3	33	2	GO:0099577
GeneOntologyBiologicalProcess	box C/D sno(s)RNA 3'-end processing	FBLL1 FBL	7.44e-06	3	33	2	GO:0000494
GeneOntologyBiologicalProcess	positive regulation of gene expression	CIRBP HNRNPA0 LARP1 TRA2A NCL FAM98A TAF15 FUS FMR1 FXR2 PAIP1	8.87e-06	1446	33	11	GO:0010628
GeneOntologyBiologicalProcess	regulation of RNA splicing	CIRBP TRA2A NCL FUS FMR1	1.83e-05	207	33	5	GO:0043484
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	CIRBP TRA2A U2AF1 NCL FMR1 HNRNPR	1.95e-05	358	33	6	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	CIRBP TRA2A U2AF1 NCL FMR1 HNRNPR	1.95e-05	358	33	6	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	CIRBP TRA2A U2AF1 NCL FMR1 HNRNPR	2.08e-05	362	33	6	GO:0000375
GeneOntologyBiologicalProcess	RNA localization	ALYREF FMR1 FXR2 FBL CHTOP	2.30e-05	217	33	5	GO:0006403
GeneOntologyBiologicalProcess	rRNA modification	FBLL1 GAR1 FBL	2.57e-05	36	33	3	GO:0000154
GeneOntologyBiologicalProcess	negative regulation of catabolic process	CIRBP HNRNPA0 LARP1 TAF15 FUS PAIP1	4.65e-05	418	33	6	GO:0009895
GeneOntologyBiologicalProcess	positive regulation of mRNA splicing, via spliceosome	CIRBP TRA2A NCL	4.73e-05	44	33	3	GO:0048026
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	CIRBP TRA2A NCL FMR1	5.19e-05	129	33	4	GO:0048024
GeneOntologyBiologicalProcess	positive regulation of mRNA processing	CIRBP TRA2A NCL	6.54e-05	49	33	3	GO:0050685
GeneOntologyBiologicalProcess	mRNA transport	ALYREF FMR1 FXR2 CHTOP	8.18e-05	145	33	4	GO:0051028
GeneOntologyBiologicalProcess	regulation of translation at synapse, modulating synaptic transmission	FMR1 FXR2	8.87e-05	9	33	2	GO:0099547
GeneOntologyBiologicalProcess	regulation of mRNA processing	CIRBP TRA2A NCL FMR1	1.14e-04	158	33	4	GO:0050684
GeneOntologyBiologicalProcess	positive regulation of long-term neuronal synaptic plasticity	FMR1 FXR2	1.35e-04	11	33	2	GO:0048170
GeneOntologyBiologicalProcess	positive regulation of RNA splicing	CIRBP TRA2A NCL	1.39e-04	63	33	3	GO:0033120
GeneOntologyBiologicalProcess	sno(s)RNA 3'-end processing	FBLL1 FBL	1.62e-04	12	33	2	GO:0031126
GeneOntologyBiologicalProcess	RNA transport	ALYREF FMR1 FXR2 CHTOP	1.69e-04	175	33	4	GO:0050658
GeneOntologyBiologicalProcess	nucleic acid transport	ALYREF FMR1 FXR2 CHTOP	1.69e-04	175	33	4	GO:0050657
GeneOntologyBiologicalProcess	establishment of RNA localization	ALYREF FMR1 FXR2 CHTOP	1.80e-04	178	33	4	GO:0051236
GeneOntologyBiologicalProcess	regulation of translation at synapse	FMR1 FXR2	1.91e-04	13	33	2	GO:0140243
GeneOntologyBiologicalProcess	sno(s)RNA processing	FBLL1 FBL	2.23e-04	14	33	2	GO:0043144
GeneOntologyBiologicalProcess	mRNA export from nucleus	ALYREF FMR1 CHTOP	2.24e-04	74	33	3	GO:0006406
GeneOntologyBiologicalProcess	mRNA destabilization	NANOS3 FXR2 PAIP1 HNRNPR	3.15e-04	206	33	4	GO:0061157
GeneOntologyBiologicalProcess	RNA destabilization	NANOS3 FXR2 PAIP1 HNRNPR	3.45e-04	211	33	4	GO:0050779
GeneOntologyBiologicalProcess	positive regulation of mRNA catabolic process	NANOS3 FXR2 PAIP1 HNRNPR	3.45e-04	211	33	4	GO:0061014
GeneOntologyBiologicalProcess	regulation of translational initiation	LARP1 FMR1 PAIP1	4.12e-04	91	33	3	GO:0006446
GeneOntologyBiologicalProcess	sno(s)RNA metabolic process	FBLL1 FBL	4.17e-04	19	33	2	GO:0016074
GeneOntologyBiologicalProcess	rRNA processing	NCL FBLL1 GAR1 FBL	4.78e-04	230	33	4	GO:0006364
GeneOntologyBiologicalProcess	RNA export from nucleus	ALYREF FMR1 CHTOP	4.82e-04	96	33	3	GO:0006405
GeneOntologyBiologicalProcess	methylation	FAM98A FBLL1 KMT2B FBL	5.10e-04	234	33	4	GO:0032259
GeneOntologyBiologicalProcess	nucleobase-containing compound transport	ALYREF FMR1 FXR2 CHTOP	6.44e-04	249	33	4	GO:0015931
GeneOntologyBiologicalProcess	negative regulation of translational initiation	LARP1 FMR1	6.70e-04	24	33	2	GO:0045947
GeneOntologyBiologicalProcess	positive regulation of catabolic process	NANOS3 LARP1 FMR1 FXR2 PAIP1 HNRNPR	7.62e-04	701	33	6	GO:0009896
GeneOntologyBiologicalProcess	regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	NANOS3 PAIP1	8.50e-04	27	33	2	GO:1900151
GeneOntologyBiologicalProcess	rRNA methylation	FBLL1 FBL	8.50e-04	27	33	2	GO:0031167
GeneOntologyBiologicalProcess	rRNA metabolic process	NCL FBLL1 GAR1 FBL	9.33e-04	275	33	4	GO:0016072
GeneOntologyBiologicalProcess	translational initiation	LARP1 FMR1 PAIP1	1.21e-03	132	33	3	GO:0006413
GeneOntologyBiologicalProcess	negative regulation of protein metabolic process	CIRBP NANOS3 LARP1 LSM14A NCL SERBP1 FMR1	1.42e-03	1088	33	7	GO:0051248
GeneOntologyBiologicalProcess	macromolecule methylation	FAM98A FBLL1 FBL	1.59e-03	145	33	3	GO:0043414
GeneOntologyBiologicalProcess	regulation of cytoplasmic translation	FMR1 PAIP1	1.60e-03	37	33	2	GO:2000765
GeneOntologyBiologicalProcess	regulation of long-term neuronal synaptic plasticity	FMR1 FXR2	1.86e-03	40	33	2	GO:0048169
GeneOntologyBiologicalProcess	ribosome biogenesis	NCL FBLL1 GAR1 FBL	1.95e-03	336	33	4	GO:0042254
GeneOntologyBiologicalProcess	DNA methylation-dependent constitutive heterochromatin formation	KMT2B MBD2	2.25e-03	44	33	2	GO:0006346
GeneOntologyBiologicalProcess	RNA modification	FBLL1 GAR1 FBL	2.76e-03	176	33	3	GO:0009451
GeneOntologyBiologicalProcess	modulation by host of viral process	FMR1 PAIP1	3.13e-03	52	33	2	GO:0044788
GeneOntologyBiologicalProcess	nuclear export	ALYREF FMR1 CHTOP	3.18e-03	185	33	3	GO:0051168
GeneOntologyBiologicalProcess	facultative heterochromatin formation	KMT2B MBD2	3.50e-03	55	33	2	GO:0140718
GeneOntologyBiologicalProcess	neuronal action potential	DPP6 FMR1	4.56e-03	63	33	2	GO:0019228
GeneOntologyBiologicalProcess	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	NANOS3 PAIP1	4.85e-03	65	33	2	GO:0000288
GeneOntologyBiologicalProcess	presynaptic modulation of chemical synaptic transmission	FMR1 FXR2	5.14e-03	67	33	2	GO:0099171
GeneOntologyBiologicalProcess	positive regulation of viral process	LARP1 FMR1	5.45e-03	69	33	2	GO:0048524
GeneOntologyBiologicalProcess	chromatin remodeling	FBLL1 KMT2B MBD2 FBL CHTOP	6.08e-03	741	33	5	GO:0006338
GeneOntologyCellularComponent	cytoplasmic stress granule	CIRBP NANOS3 LARP1 LSM14A FMR1 FXR2 UBAP2L	1.34e-10	96	33	7	GO:0010494
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	CIRBP NANOS3 LARP1 LSM14A NCL FMR1 FXR2 UBAP2L	7.12e-09	269	33	8	GO:0036464
GeneOntologyCellularComponent	ribonucleoprotein granule	CIRBP NANOS3 LARP1 LSM14A NCL FMR1 FXR2 UBAP2L	1.18e-08	287	33	8	GO:0035770
GeneOntologyCellularComponent	ribonucleoprotein complex	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF LSM14A NCL ILF2 FBLL1 FMR1 GAR1 FBL HNRNPR	1.27e-08	1194	33	13	GO:1990904
GeneOntologyCellularComponent	dense fibrillar component	NCL GAR1 FBL	1.25e-07	7	33	3	GO:0001651
GeneOntologyCellularComponent	Cajal body	U2AF1 FBLL1 FMR1 GAR1 FBL	2.02e-07	84	33	5	GO:0015030
GeneOntologyCellularComponent	nuclear protein-containing complex	CIRBP TRA2A U2AF1 ALYREF NCL KMT2B GAR1 MBD2 UBAP2L CCDC9 CHTOP HNRNPR	6.16e-07	1377	33	12	GO:0140513
GeneOntologyCellularComponent	spliceosomal complex	CIRBP TRA2A U2AF1 ALYREF NCL HNRNPR	9.70e-07	215	33	6	GO:0005681
GeneOntologyCellularComponent	sno(s)RNA-containing ribonucleoprotein complex	FBLL1 GAR1 FBL	1.72e-05	32	33	3	GO:0005732
GeneOntologyCellularComponent	box C/D RNP complex	FBLL1 FBL	5.05e-05	7	33	2	GO:0170049
GeneOntologyCellularComponent	box C/D methylation guide snoRNP complex	FBLL1 FBL	5.05e-05	7	33	2	GO:0031428
GeneOntologyCellularComponent	nuclear body	U2AF1 ALYREF FBLL1 FMR1 GAR1 RBM27 FBL CHTOP	6.23e-05	903	33	8	GO:0016604
GeneOntologyCellularComponent	fibrillar center	NCL FBLL1 GAR1 FBL	1.03e-04	156	33	4	GO:0001650
GeneOntologyCellularComponent	transcription export complex	ALYREF CHTOP	1.58e-04	12	33	2	GO:0000346
GeneOntologyCellularComponent	dendritic spine head	FUS FMR1	2.86e-04	16	33	2	GO:0044327
GeneOntologyCellularComponent	catalytic step 2 spliceosome	U2AF1 ALYREF HNRNPR	4.78e-04	97	33	3	GO:0071013
GeneOntologyCellularComponent	exon-exon junction complex	ALYREF CCDC9	4.98e-04	21	33	2	GO:0035145
GeneOntologyCellularComponent	postsynaptic cytosol	FUS FMR1	2.29e-03	45	33	2	GO:0099524
GeneOntologyCellularComponent	presynaptic cytosol	FUS FMR1	2.71e-03	49	33	2	GO:0099523
GeneOntologyCellularComponent	nuclear speck	U2AF1 ALYREF RBM27 CHTOP	4.54e-03	431	33	4	GO:0016607
GeneOntologyCellularComponent	cytosolic region	FUS FMR1	5.46e-03	70	33	2	GO:0099522
GeneOntologyCellularComponent	small-subunit processome	FBLL1 FBL	6.40e-03	76	33	2	GO:0032040
GeneOntologyCellularComponent	P-body	NANOS3 LSM14A	1.13e-02	102	33	2	GO:0000932
GeneOntologyCellularComponent	preribosome	FBLL1 FBL	1.39e-02	114	33	2	GO:0030684
HumanPheno	Oromandibular dystonia	FUS KMT2B UBAP2L	7.12e-06	21	10	3	HP:0012048
HumanPheno	Retrocollis	FUS KMT2B	1.24e-04	9	10	2	HP:0002544
HumanPheno	Nystagmus	DPP6 PLEKHG2 FUS FMR1 KMT2B UBAP2L AHDC1 HNRNPR	1.39e-04	1102	10	8	HP:0000639
HumanPheno	Abnormal involuntary eye movements	DPP6 PLEKHG2 FUS FMR1 KMT2B UBAP2L AHDC1 HNRNPR	1.60e-04	1123	10	8	HP:0012547
Domain	RRM_1	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 FUS RBM27 HNRNPR	1.23e-12	208	32	10	PF00076
Domain	RRM	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 FUS RBM27 HNRNPR	1.88e-12	217	32	10	SM00360
Domain	RRM_dom	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 FUS RBM27 HNRNPR	2.95e-12	227	32	10	IPR000504
Domain	RRM	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 FUS RBM27 HNRNPR	3.36e-12	230	32	10	PS50102
Domain	Nucleotide-bd_a/b_plait	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 FUS RBM27 HNRNPR	1.05e-11	258	32	10	IPR012677
Domain	-	CIRBP HNRNPA0 TRA2A ALYREF NCL TAF15 FUS RBM27 HNRNPR	2.07e-10	244	32	9	3.30.70.330
Domain	FoP_C	ALYREF CHTOP	2.84e-06	2	32	2	IPR025715
Domain	FoP_duplication	ALYREF CHTOP	2.84e-06	2	32	2	PF13865
Domain	FoP_duplication	ALYREF CHTOP	2.84e-06	2	32	2	SM01218
Domain	FXMRP1_C_core	FMR1 FXR2	8.52e-06	3	32	2	IPR022034
Domain	Agenet	FMR1 FXR2	8.52e-06	3	32	2	PF05641
Domain	FXMRP1_C_core	FMR1 FXR2	8.52e-06	3	32	2	PF12235
Domain	Agenet-like_dom	FMR1 FXR2	8.52e-06	3	32	2	IPR008395
Domain	AGENET_LIKE	FMR1 FXR2	8.52e-06	3	32	2	PS51641
Domain	-	TAF15 FUS	1.27e-04	10	32	2	4.10.1060.10
Domain	zf-RanBP	TAF15 FUS	6.43e-04	22	32	2	PF00641
Domain	ZnF_RBZ	TAF15 FUS	7.04e-04	23	32	2	SM00547
Domain	RRM_dom_euk	CIRBP NCL	7.04e-04	23	32	2	IPR003954
Domain	RRM_1	CIRBP NCL	7.04e-04	23	32	2	SM00361
Domain	ZF_RANBP2_2	TAF15 FUS	7.04e-04	23	32	2	PS50199
Domain	ZF_RANBP2_1	TAF15 FUS	7.67e-04	24	32	2	PS01358
Domain	Znf_RanBP2	TAF15 FUS	8.32e-04	25	32	2	IPR001876
Domain	AT_hook	KMT2B AHDC1	9.72e-04	27	32	2	SM00384
Domain	AT_hook_DNA-bd_motif	KMT2B AHDC1	9.72e-04	27	32	2	IPR017956
Domain	KH_1	FMR1 FXR2	1.92e-03	38	32	2	PF00013
Domain	-	FMR1 FXR2	2.03e-03	39	32	2	3.30.1370.10
Domain	KH	FMR1 FXR2	2.13e-03	40	32	2	SM00322
Domain	KH_dom	FMR1 FXR2	2.13e-03	40	32	2	IPR004087
Domain	KH_TYPE_1	FMR1 FXR2	2.35e-03	42	32	2	PS50084
Domain	KH_dom_type_1	FMR1 FXR2	2.57e-03	44	32	2	IPR004088
Domain	zf-CCCH	U2AF1 RBM27	3.18e-03	49	32	2	PF00642
Domain	Znf_CCCH	U2AF1 RBM27	4.43e-03	58	32	2	IPR000571
Domain	ZF_C3H1	U2AF1 RBM27	4.43e-03	58	32	2	PS50103
Pathway	WP_MRNA_PROCESSING	CIRBP HNRNPA0 U2AF1 ALYREF NCL TAF15 FUS FMR1 FXR2 FBL HNRNPR	2.61e-10	451	27	11	MM15946
Pathway	REACTOME_METABOLISM_OF_RNA	U2AF1 ALYREF NCL FUS GAR1 FBL PAIP1 CHTOP HNRNPR	4.81e-06	724	27	9	M16843
Pathway	REACTOME_METABOLISM_OF_RNA	U2AF1 ALYREF NCL FUS FBL PAIP1 CHTOP HNRNPR	1.29e-05	612	27	8	MM15547
Pathway	BIOCARTA_SARS_PATHWAY	NCL FBL	7.38e-05	7	27	2	M5374
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	U2AF1 ALYREF FUS CHTOP HNRNPR	1.60e-04	277	27	5	MM15414
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	U2AF1 ALYREF FUS CHTOP HNRNPR	1.77e-04	283	27	5	M13087
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION	U2AF1 ALYREF CHTOP	2.20e-04	62	27	3	MM15426
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION	U2AF1 ALYREF CHTOP	2.77e-04	67	27	3	M27694
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	U2AF1 ALYREF CHTOP	5.38e-04	84	27	3	M725
Pathway	REACTOME_MRNA_SPLICING	U2AF1 ALYREF FUS HNRNPR	5.44e-04	201	27	4	MM15411
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	U2AF1 ALYREF CHTOP	5.77e-04	86	27	3	MM15413
Pathway	REACTOME_MRNA_SPLICING	U2AF1 ALYREF FUS HNRNPR	6.65e-04	212	27	4	M14033
Pathway	WP_MRNA_PROCESSING	U2AF1 FUS HNRNPR	1.74e-03	126	27	3	M39406
Pathway	KEGG_SPLICEOSOME	TRA2A U2AF1 ALYREF	1.78e-03	127	27	3	M2044
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 GAR1 RBM27 FXR2 UBAP2L FBL CCDC9 CHTOP HNRNPR	1.27e-28	807	33	22	22681889
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FUS FBLL1 FMR1 KMT2B RBM27 FXR2 FBL AHDC1 CHTOP HNRNPR	2.77e-26	847	33	21	35850772
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 GAR1 RBM27 FXR2 FBL PAIP1 CHTOP HNRNPR	5.90e-26	713	33	20	29802200
Pubmed	The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.	CIRBP LARP1 ALYREF TAF15 SERBP1 ILF2 FUS FMR1 GAR1 MBD2 FXR2 FBL PAIP1 HNRNPR	2.35e-25	147	33	14	28977470
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FMR1 GAR1 FXR2 UBAP2L FBL AHDC1 CHTOP HNRNPR	1.81e-23	615	33	18	31048545
Pubmed	Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 FXR2 UBAP2L FBL HNRNPR	1.55e-22	421	33	16	34650049
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL FAM98A ILF2 FUS FBLL1 GAR1 RBM27 FXR2 FBL CHTOP HNRNPR	4.03e-22	731	33	18	29298432
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL FAM98A TAF15 ILF2 FUS FXR2 FBL CHTOP HNRNPR	1.60e-20	430	33	15	38172120
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CIRBP LARP1 TRA2A AVEN U2AF1 ALYREF LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FMR1 GAR1 MBD2 RBM27 FXR2 UBAP2L FBL CHTOP	2.52e-20	1371	33	20	36244648
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FUS GAR1 RBM27 UBAP2L FBL CHTOP HNRNPR	3.54e-20	1153	33	19	29845934
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 MBD2 FXR2 FBL CHTOP HNRNPR	5.13e-20	605	33	16	28977666
Pubmed	Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.	HNRNPA0 LARP1 TRA2A ALYREF NCL FAM98A SERBP1 ILF2 FUS FMR1 UBAP2L FBL HNRNPR	8.45e-20	260	33	13	36199071
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF NCL TAF15 SERBP1 ILF2 FUS KMT2B FXR2 UBAP2L FBL CHTOP HNRNPR	6.66e-19	711	33	16	33022573
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	CIRBP HNRNPA0 LARP1 ALYREF LSM14A SERBP1 FUS FMR1 FXR2 UBAP2L CCDC9 HNRNPR	6.64e-18	258	33	12	37794589
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	LARP1 U2AF1 ALYREF LSM14A NCL TAF15 SERBP1 FUS FMR1 MBD2 FXR2 UBAP2L FBL CHTOP HNRNPR	8.61e-18	655	33	15	35819319
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	LARP1 ALYREF LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 UBAP2L CCDC9 CHTOP HNRNPR	3.31e-17	551	33	14	34728620
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	LARP1 ALYREF LSM14A NCL FAM98A SERBP1 ILF2 FMR1 GAR1 RBM27 FXR2 UBAP2L FBL CHTOP HNRNPR	7.62e-17	759	33	15	35915203
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A SERBP1 ILF2 FUS GAR1 FXR2 UBAP2L FBL PAIP1 HNRNPR	9.03e-17	971	33	16	33306668
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL SERBP1 ILF2 FUS FMR1 GAR1 RBM27 FXR2 FBL CHTOP HNRNPR	1.86e-16	1257	33	17	36526897
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	LARP1 TRA2A NCL FAM98A SERBP1 ILF2 FUS FMR1 GAR1 FXR2 UBAP2L FBL CHTOP HNRNPR	1.94e-16	626	33	14	33644029
Pubmed	The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL SERBP1 ILF2 FBL CHTOP HNRNPR	2.17e-16	239	33	11	26641092
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 FUS FMR1 RBM27 FXR2 HNRNPR	2.37e-16	347	33	12	16033648
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 ILF2 FUS FMR1 KMT2B GAR1 MBD2 RBM27 FBL AHDC1 CHTOP HNRNPR	3.01e-16	1294	33	17	30804502
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	HNRNPA0 LARP1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS RBM27 FXR2 UBAP2L FBL HNRNPR	5.84e-16	678	33	14	30209976
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 ILF2 FUS FBLL1 GAR1 MBD2 RBM27 FBL HNRNPR	3.72e-15	989	33	15	36424410
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	HNRNPA0 LARP1 TRA2A ALYREF NCL TAF15 ILF2 FUS FMR1 FXR2 FBL HNRNPR	4.15e-15	441	33	12	31239290
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	HNRNPA0 LARP1 U2AF1 ALYREF NCL TAF15 SERBP1 ILF2 FUS FMR1 FXR2 FBL AHDC1 CCDC9 CHTOP HNRNPR	4.46e-15	1247	33	16	27684187
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	HNRNPA0 LARP1 TRA2A U2AF1 NCL FAM98A TAF15 SERBP1 FUS NFATC2IP MBD2 RBM27 UBAP2L AHDC1 BRWD3	5.93e-15	1021	33	15	26760575
Pubmed	Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis.	LARP1 TRA2A U2AF1 ALYREF NCL SERBP1 ILF2 FUS FBL CHTOP	1.38e-14	236	33	10	36339263
Pubmed	Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells.	CIRBP HNRNPA0 TRA2A ALYREF NCL TAF15 GAR1 FBL HNRNPR	1.71e-14	153	33	9	28225217
Pubmed	Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.	CIRBP HNRNPA0 U2AF1 ALYREF NCL ILF2 FUS HNRNPR	1.93e-14	90	33	8	23151878
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	HNRNPA0 LARP1 TRA2A ALYREF LSM14A NCL SERBP1 ILF2 FUS FMR1 RBM27 CCDC9 CHTOP	3.21e-14	701	33	13	30196744
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL ILF2 FMR1 FXR2 UBAP2L FBL CHTOP HNRNPR	4.06e-14	714	33	13	28302793
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	CIRBP HNRNPA0 LARP1 U2AF1 NCL FAM98A TAF15 ILF2 GAR1 FXR2 FBL CCDC9 HNRNPR	4.76e-14	723	33	13	34133714
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS UBAP2L HNRNPR	4.93e-14	725	33	13	27025967
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS GAR1 RBM27 UBAP2L HNRNPR	6.27e-14	954	33	14	36373674
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF NCL TAF15 SERBP1 ILF2 FUS UBAP2L CHTOP HNRNPR	1.98e-13	809	33	13	32129710
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF LSM14A NCL FAM98A SERBP1 ILF2 FUS GAR1 FBL CHTOP HNRNPR	2.90e-13	1335	33	15	29229926
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	HNRNPA0 LARP1 TRA2A ALYREF NCL FAM98A ILF2 FUS FMR1 FXR2 UBAP2L	3.00e-13	462	33	11	31138677
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	HNRNPA0 ALYREF NCL TAF15 SERBP1 ILF2 FUS FMR1 GAR1 FBL CHTOP HNRNPR	4.22e-13	652	33	12	31180492
Pubmed	Interactome analysis of the human Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (hMTr1) protein.	CIRBP LARP1 ALYREF NCL ILF2 FUS FXR2 HNRNPR	6.39e-13	138	33	8	30320910
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A SERBP1 ILF2 FUS GAR1 FXR2 UBAP2L FBL HNRNPR	6.70e-13	1415	33	15	28515276
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL SERBP1 ILF2 FUS FMR1 GAR1 UBAP2L FBL CHTOP HNRNPR	7.41e-13	1425	33	15	30948266
Pubmed	SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.	LSM14A NCL TAF15 SERBP1 FUS FMR1 RBM27 UBAP2L HNRNPR	1.23e-12	245	33	9	35652658
Pubmed	RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway.	CIRBP LARP1 NCL SERBP1 FUS UBAP2L FBL HNRNPR	1.73e-12	156	33	8	26170170
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 ILF2 FUS GAR1 UBAP2L FBL CHTOP HNRNPR	3.85e-12	1024	33	13	24711643
Pubmed	Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations.	ALYREF NCL ILF2 FUS GAR1 FBL HNRNPR	3.94e-12	96	33	7	25948554
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	HNRNPA0 LARP1 TRA2A NCL FAM98A TAF15 ILF2 FUS GAR1 RBM27 FXR2 UBAP2L FBL HNRNPR	4.91e-12	1318	33	14	30463901
Pubmed	A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.	CIRBP HNRNPA0 U2AF1 LSM14A NCL SERBP1 ILF2 FUS UBAP2L	4.92e-12	286	33	9	32041737
Pubmed	Revealing A-Raf functions through its interactome.	HNRNPA0 U2AF1 ALYREF NCL TAF15 ILF2 FUS FBL	7.44e-12	187	33	8	29777862
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	CIRBP HNRNPA0 LARP1 ALYREF LSM14A ILF2 FUS KMT2B MBD2 RBM27 AHDC1 CHTOP HNRNPR	9.74e-12	1103	33	13	34189442
Pubmed	SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.	ALYREF NCL FAM98A SERBP1 ILF2 FMR1 GAR1 FXR2 FBL HNRNPR	1.12e-11	463	33	10	34901782
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	LARP1 TRA2A ALYREF TAF15 ILF2 FUS FBLL1 RBM27 CCDC9 CHTOP HNRNPR	1.25e-11	653	33	11	33742100
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	LARP1 ALYREF NCL TAF15 SERBP1 ILF2 FUS FMR1 FXR2 UBAP2L FBL	1.25e-11	653	33	11	22586326
Pubmed	Interactomic analysis of REST/NRSF and implications of its functional links with the transcription suppressor TRIM28 during neuronal differentiation.	HNRNPA0 ALYREF NCL TAF15 SERBP1 ILF2 FBL HNRNPR	1.55e-11	205	33	8	27976729
Pubmed	LINKIN, a new transmembrane protein necessary for cell adhesion.	HNRNPA0 U2AF1 ALYREF LSM14A NCL SERBP1 ILF2 FUS FBL HNRNPR	1.59e-11	480	33	10	25437307
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	HNRNPA0 U2AF1 ALYREF NCL FAM98A SERBP1 ILF2 FMR1 FXR2 HNRNPR	1.80e-11	486	33	10	30940648
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	HNRNPA0 LARP1 NCL FAM98A TAF15 ILF2 FUS UBAP2L FBL HNRNPR	2.11e-11	494	33	10	26831064
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	CIRBP HNRNPA0 U2AF1 ALYREF NCL ILF2 FUS GAR1 UBAP2L FBL HNRNPR	2.92e-11	707	33	11	19738201
Pubmed	GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer.	LARP1 TRA2A ALYREF NCL SERBP1 ILF2 FUS FMR1	3.05e-11	223	33	8	33731348
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	HNRNPA0 LARP1 NCL FAM98A SERBP1 ILF2 FBL HNRNPR	3.05e-11	223	33	8	20020773
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	HNRNPA0 LARP1 U2AF1 ALYREF NCL SERBP1 ILF2 FUS FMR1 FXR2 FBL HNRNPR	3.33e-11	949	33	12	36574265
Pubmed	Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.	HNRNPA0 LARP1 NCL ILF2 FUS PAIP1 HNRNPR	4.69e-11	136	33	7	26979993
Pubmed	Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.	HNRNPA0 ALYREF NCL ILF2 FUS FBL CHTOP HNRNPR	6.24e-11	244	33	8	30349055
Pubmed	Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.	LARP1 U2AF1 LSM14A NCL FAM98A ILF2 GAR1 FBL HNRNPR	6.62e-11	383	33	9	29331416
Pubmed	Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.	CIRBP HNRNPA0 LARP1 ALYREF NCL FAM98A ILF2 FUS GAR1	6.78e-11	384	33	9	31059266
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	HNRNPA0 LARP1 U2AF1 ALYREF NCL ILF2 FMR1 GAR1 FBL CHTOP	1.43e-10	601	33	10	33658012
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CIRBP HNRNPA0 TRA2A U2AF1 NCL TAF15 ILF2 FBLL1 GAR1 RBM27 AHDC1 HNRNPR	1.50e-10	1082	33	12	38697112
Pubmed	A protein-RNA interaction atlas of the ribosome biogenesis factor AATF.	LARP1 U2AF1 NCL FXR2 FBL CHTOP HNRNPR	1.61e-10	162	33	7	31363146
Pubmed	Comparative Proteomics and Interactome Analysis of the SARS-CoV-2 Nucleocapsid Protein in Human and Bat Cell Lines.	LARP1 ALYREF NCL SERBP1 FXR2 CHTOP HNRNPR	2.08e-10	168	33	7	39066279
Pubmed	The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus.	TRA2A ALYREF ILF2 FMR1 FBL CCDC9 CHTOP	2.17e-10	169	33	7	23084401
Pubmed	EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3.	CIRBP HNRNPA0 ALYREF NCL ILF2 FUS HNRNPR	2.66e-10	174	33	7	35031058
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	HNRNPA0 LARP1 TRA2A U2AF1 NCL TAF15 ILF2 UBAP2L FBL CHTOP	2.67e-10	641	33	10	36057605
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	CIRBP LARP1 U2AF1 ALYREF NCL SERBP1 ILF2 FUS RBM27 FXR2 UBAP2L HNRNPR	2.98e-10	1149	33	12	35446349
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	HNRNPA0 LARP1 ALYREF LSM14A TAF15 SERBP1 FUS GAR1 FBL CCDC9 CHTOP HNRNPR	3.17e-10	1155	33	12	20360068
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	HNRNPA0 TRA2A U2AF1 ALYREF FUS FMR1 GAR1 FXR2 FBL HNRNPR	3.54e-10	660	33	10	32780723
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	HNRNPA0 LARP1 U2AF1 NCL FAM98A SERBP1 ILF2 FBLL1 UBAP2L FBL	3.80e-10	665	33	10	30457570
Pubmed	The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression.	HNRNPA0 LARP1 SERBP1 FMR1 FXR2 UBAP2L	4.19e-10	97	33	6	37151849
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	LARP1 U2AF1 LSM14A FAM98A FMR1 FXR2 UBAP2L FBL	4.73e-10	315	33	8	26777405
Pubmed	Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.	HNRNPA0 LARP1 ALYREF NCL ILF2 FUS UBAP2L FBL HNRNPR	5.91e-10	491	33	9	22623428
Pubmed	Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma.	HNRNPA0 LARP1 U2AF1 ALYREF LSM14A SERBP1 FUS FBL	6.66e-10	329	33	8	34316702
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	TRA2A ALYREF SERBP1 FMR1 GAR1 MBD2 FXR2 HNRNPR	6.82e-10	330	33	8	33301849
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	LARP1 TRA2A U2AF1 SERBP1 FUS FXR2 UBAP2L	7.82e-10	203	33	7	35012549
Pubmed	ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.	CIRBP ALYREF NCL TAF15 SERBP1 ILF2 FUS HNRNPR	7.86e-10	336	33	8	31253590
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	HNRNPA0 LARP1 TRA2A U2AF1 NCL FAM98A TAF15 SERBP1 ILF2 FUS FBL HNRNPR	8.28e-10	1257	33	12	37317656
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	HNRNPA0 NCL TAF15 ILF2 FUS RBM27 FBL HNRNPR	8.62e-10	340	33	8	24332808
Pubmed	hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.	HNRNPA0 LARP1 NCL TAF15 SERBP1 ILF2 FUS HNRNPR	9.89e-10	346	33	8	25324306
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	LARP1 TRA2A ALYREF NCL SERBP1 ILF2 KMT2B FXR2 CHTOP HNRNPR	1.01e-09	736	33	10	29676528
Pubmed	Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.	LARP1 SERBP1 FMR1 RBM27 FXR2 HNRNPR	1.12e-09	114	33	6	31553912
Pubmed	SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication.	HNRNPA0 ALYREF NCL FAM98A SERBP1 FUS HNRNPR	1.20e-09	216	33	7	37640791
Pubmed	Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.	ALYREF NCL ILF2 FBL AHDC1 PAIP1	1.24e-09	116	33	6	21282530
Pubmed	Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.	LARP1 FAM98A SERBP1 ILF2 FBL HNRNPR	1.60e-09	121	33	6	34029587
Pubmed	Elucidation of the 14-3-3ζ interactome reveals critical roles of RNA-splicing factors during adipogenesis.	ALYREF FAM98A TAF15 FUS FMR1 FXR2	1.69e-09	122	33	6	29530978
Pubmed	A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.	LARP1 ALYREF SERBP1 ILF2 FMR1 GAR1 RBM27 UBAP2L FBL CHTOP	1.90e-09	786	33	10	29128334
Pubmed	Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells.	NCL ILF2 FMR1 FXR2 FBL	2.26e-09	57	33	5	17932509
Pubmed	SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation.	NCL FAM98A ILF2 FUS UBAP2L HNRNPR	2.48e-09	130	33	6	32905556
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	HNRNPA0 LARP1 TRA2A TAF15 ILF2 FUS HNRNPR	2.81e-09	244	33	7	29884807
Pubmed	Identification of proteins associated with ligand-activated estrogen receptor α in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS.	HNRNPA0 NCL ILF2 FUS FMR1 UBAP2L HNRNPR	2.89e-09	245	33	7	21182205
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	HNRNPA0 LARP1 ALYREF NCL TAF15 SERBP1 FUS UBAP2L	3.02e-09	399	33	8	35987950
Pubmed	Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex.	NCL FMR1 FXR2	3.11e-09	4	33	3	10567518
Interaction	SNRNP70 interactions	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 GAR1 RBM27 FXR2 FBL CCDC9 PAIP1 CHTOP HNRNPR	4.78e-20	984	33	21	int:SNRNP70
Interaction	WDR77 interactions	CIRBP LARP1 ALYREF NCL TAF15 SERBP1 ILF2 FUS FMR1 GAR1 MBD2 FXR2 FBL PAIP1 CHTOP HNRNPR	7.14e-20	361	33	16	int:WDR77
Interaction	ZC3H18 interactions	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL FAM98A TAF15 ILF2 FUS FBLL1 GAR1 RBM27 FXR2 FBL PAIP1 CHTOP HNRNPR	1.61e-19	877	33	20	int:ZC3H18
Interaction	BMI1 interactions	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL TAF15 SERBP1 ILF2 FUS MBD2 FXR2 UBAP2L FBL PAIP1 CHTOP	9.55e-19	659	33	18	int:BMI1
Interaction	DOT1L interactions	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL FAM98A TAF15 SERBP1 FBLL1 FMR1 RBM27 FXR2 FBL AHDC1 CHTOP HNRNPR	1.10e-18	807	33	19	int:DOT1L
Interaction	WWP2 interactions	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FMR1 GAR1 FXR2 UBAP2L FBL AHDC1 PAIP1 CHTOP HNRNPR	2.33e-18	840	33	19	int:WWP2
Interaction	TRIM31 interactions	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 FXR2 UBAP2L FBL HNRNPR	2.78e-18	454	33	16	int:TRIM31
Interaction	PRMT1 interactions	CIRBP LARP1 ALYREF LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 GAR1 NFATC2IP MBD2 UBAP2L FBL CCDC9 CHTOP HNRNPR	1.51e-17	929	33	19	int:PRMT1
Interaction	MYCN interactions	CIRBP HNRNPA0 LARP1 TRA2A ALYREF LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 GAR1 FXR2 UBAP2L FBL CCDC9 PAIP1 CHTOP HNRNPR	4.39e-17	1373	33	21	int:MYCN
Interaction	PRMT8 interactions	CIRBP ALYREF LSM14A TAF15 SERBP1 FUS GAR1 FBL CHTOP HNRNPR	7.21e-16	104	33	10	int:PRMT8
Interaction	RC3H2 interactions	HNRNPA0 LARP1 ALYREF LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 RBM27 FXR2 UBAP2L FBL HNRNPR	1.20e-15	667	33	16	int:RC3H2
Interaction	RC3H1 interactions	CIRBP HNRNPA0 LARP1 ALYREF LSM14A NCL FAM98A SERBP1 ILF2 FUS FMR1 RBM27 FXR2 UBAP2L FBL HNRNPR	1.52e-15	677	33	16	int:RC3H1
Interaction	CHD3 interactions	HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 MBD2 FXR2 FBL CHTOP HNRNPR	8.64e-15	757	33	16	int:CHD3
Interaction	RNF113A interactions	LARP1 U2AF1 ALYREF LSM14A NCL TAF15 SERBP1 FUS FMR1 MBD2 FXR2 UBAP2L FBL CHTOP HNRNPR	5.47e-14	692	33	15	int:RNF113A
Interaction	DDRGK1 interactions	CIRBP HNRNPA0 LARP1 TRA2A ALYREF NCL FAM98A SERBP1 ILF2 FUS FMR1 GAR1 RBM27 FXR2 FBL PAIP1 CHTOP HNRNPR	6.88e-14	1249	33	18	int:DDRGK1
Interaction	KIF20A interactions	NANOS3 HNRNPA0 LARP1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS FBLL1 FMR1 GAR1 FXR2 UBAP2L FBL HNRNPR	7.39e-14	1052	33	17	int:KIF20A
Interaction	FAM120A interactions	LARP1 ALYREF LSM14A TAF15 SERBP1 ILF2 FUS FMR1 UBAP2L FBL PAIP1 HNRNPR	1.54e-13	349	33	12	int:FAM120A
Interaction	NCBP1 interactions	LARP1 ALYREF NCL TAF15 SERBP1 ILF2 FUS FMR1 RBM27 FBL PAIP1 HNRNPR	1.77e-13	353	33	12	int:NCBP1
Interaction	PRC1 interactions	NANOS3 HNRNPA0 LARP1 TRA2A ALYREF NCL TAF15 SERBP1 ILF2 FUS FBLL1 FMR1 GAR1 FXR2 FBL HNRNPR	4.16e-13	973	33	16	int:PRC1
Interaction	FZR1 interactions	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A SERBP1 ILF2 FUS FMR1 GAR1 FXR2 UBAP2L FBL PAIP1 HNRNPR	4.27e-13	1172	33	17	int:FZR1
Interaction	SUZ12 interactions	LARP1 TRA2A U2AF1 ALYREF NCL TAF15 ILF2 FUS FMR1 MBD2 FXR2 FBL AHDC1 CHTOP	4.71e-13	644	33	14	int:SUZ12
Interaction	PSPC1 interactions	HNRNPA0 LARP1 AVEN ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS FMR1 FXR2 HNRNPR	6.13e-13	515	33	13	int:PSPC1
Interaction	CIT interactions	NANOS3 HNRNPA0 LARP1 TRA2A ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS FBLL1 GAR1 RBM27 FXR2 UBAP2L FBL HNRNPR	8.83e-13	1450	33	18	int:CIT
Interaction	TDRD3 interactions	LSM14A FAM98A SERBP1 FUS FMR1 FXR2 UBAP2L FBL CCDC9 PAIP1	1.01e-12	212	33	10	int:TDRD3
Interaction	UFL1 interactions	CIRBP HNRNPA0 LARP1 TRA2A ALYREF LSM14A NCL FAM98A SERBP1 ILF2 FUS FMR1 GAR1 FXR2 FBL HNRNPR	1.01e-12	1031	33	16	int:UFL1
Interaction	HDLBP interactions	CIRBP LARP1 TRA2A U2AF1 ALYREF TAF15 SERBP1 ILF2 FMR1 GAR1 RBM27 FXR2 UBAP2L FBL CHTOP	1.17e-12	855	33	15	int:HDLBP
Interaction	MEPCE interactions	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL TAF15 SERBP1 ILF2 FUS FBL CHTOP HNRNPR	1.25e-12	859	33	15	int:MEPCE
Interaction	PABPC1 interactions	LARP1 TRA2A U2AF1 ALYREF LSM14A NCL TAF15 SERBP1 ILF2 FUS FMR1 UBAP2L PAIP1 HNRNPR	1.43e-12	699	33	14	int:PABPC1
Interaction	ATXN2 interactions	LARP1 TRA2A LSM14A NCL FAM98A SERBP1 ILF2 FMR1 FXR2 UBAP2L HNRNPR	1.47e-12	312	33	11	int:ATXN2
Interaction	SYNCRIP interactions	HNRNPA0 U2AF1 ALYREF LSM14A NCL TAF15 SERBP1 ILF2 FUS FMR1 GAR1 FBL PAIP1 HNRNPR	2.17e-12	721	33	14	int:SYNCRIP
Interaction	CAND1 interactions	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS GAR1 FXR2 PAIP1 HNRNPR	2.22e-12	894	33	15	int:CAND1
Interaction	CUL4B interactions	CIRBP HNRNPA0 LARP1 TRA2A ALYREF NCL TAF15 SERBP1 ILF2 FUS GAR1 FBL BRWD3 HNRNPR	2.47e-12	728	33	14	int:CUL4B
Interaction	PABPC4 interactions	LARP1 TRA2A ALYREF NCL TAF15 SERBP1 ILF2 FUS UBAP2L FBL PAIP1 HNRNPR	2.50e-12	442	33	12	int:PABPC4
Interaction	OBSL1 interactions	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 ILF2 FUS GAR1 FXR2 UBAP2L FBL CHTOP HNRNPR	2.52e-12	902	33	15	int:OBSL1
Interaction	WDR5 interactions	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF NCL TAF15 SERBP1 ILF2 FUS KMT2B FXR2 UBAP2L FBL CHTOP HNRNPR	2.74e-12	1101	33	16	int:WDR5
Interaction	UPF1 interactions	HNRNPA0 TRA2A ALYREF LSM14A SERBP1 ILF2 FUS FMR1 FXR2 UBAP2L FBL PAIP1 HNRNPR	2.81e-12	581	33	13	int:UPF1
Interaction	HEXIM1 interactions	CIRBP HNRNPA0 U2AF1 ALYREF LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FUS RBM27 UBAP2L CHTOP HNRNPR	3.00e-12	913	33	15	int:HEXIM1
Interaction	LARP7 interactions	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL TAF15 SERBP1 ILF2 FUS GAR1 FBL CHTOP HNRNPR	3.23e-12	1113	33	16	int:LARP7
Interaction	LARP4B interactions	LARP1 TRA2A LSM14A FAM98A SERBP1 FMR1 FXR2 UBAP2L FBL PAIP1	3.46e-12	240	33	10	int:LARP4B
Interaction	BTF3 interactions	LARP1 TRA2A NCL FAM98A SERBP1 ILF2 FUS FMR1 GAR1 FXR2 UBAP2L FBL CHTOP HNRNPR	8.61e-12	799	33	14	int:BTF3
Interaction	HECTD1 interactions	LARP1 ALYREF LSM14A NCL FAM98A SERBP1 ILF2 FMR1 GAR1 RBM27 FXR2 UBAP2L FBL CHTOP HNRNPR	8.73e-12	984	33	15	int:HECTD1
Interaction	FBL interactions	LARP1 U2AF1 LSM14A NCL TAF15 SERBP1 FMR1 GAR1 FXR2 UBAP2L FBL AHDC1 HNRNPR	9.28e-12	639	33	13	int:FBL
Interaction	HNRNPU interactions	HNRNPA0 LARP1 TRA2A AVEN U2AF1 ALYREF LSM14A NCL TAF15 SERBP1 ILF2 FUS FMR1 FBL HNRNPR	1.79e-11	1035	33	15	int:HNRNPU
Interaction	RBM39 interactions	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL TAF15 ILF2 FUS FMR1 FXR2 UBAP2L FBL CHTOP HNRNPR	1.97e-11	1042	33	15	int:RBM39
Interaction	MECP2 interactions	CIRBP HNRNPA0 TRA2A U2AF1 NCL TAF15 ILF2 FUS FBLL1 GAR1 MBD2 RBM27 FXR2 FBL AHDC1 HNRNPR	2.89e-11	1287	33	16	int:MECP2
Interaction	SFPQ interactions	U2AF1 ALYREF LSM14A FAM98A TAF15 SERBP1 ILF2 FUS FMR1 RBM27 FXR2 HNRNPR	4.18e-11	563	33	12	int:SFPQ
Interaction	HNRNPM interactions	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL TAF15 SERBP1 ILF2 FUS MBD2 FXR2 HNRNPR	4.33e-11	723	33	13	int:HNRNPM
Interaction	ACE2 interactions	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS UBAP2L FBL CHTOP HNRNPR	4.58e-11	1106	33	15	int:ACE2
Interaction	CMTR1 interactions	CIRBP LARP1 ALYREF NCL SERBP1 ILF2 FUS FXR2 HNRNPR	5.29e-11	218	33	9	int:CMTR1
Interaction	IL7R interactions	CIRBP HNRNPA0 U2AF1 ALYREF NCL ILF2 FUS HNRNPR	5.63e-11	141	33	8	int:IL7R
Interaction	DAZL interactions	LSM14A FAM98A TAF15 FMR1 FXR2 UBAP2L PAIP1 HNRNPR	7.05e-11	145	33	8	int:DAZL
Interaction	CHD4 interactions	HNRNPA0 LARP1 U2AF1 NCL TAF15 SERBP1 ILF2 FUS FMR1 MBD2 FXR2 FBL CHTOP HNRNPR	7.28e-11	938	33	14	int:CHD4
Interaction	BTRC interactions	HNRNPA0 LARP1 TRA2A ALYREF NCL FAM98A SERBP1 ILF2 FUS FMR1 UBAP2L FBL HNRNPR	1.02e-10	775	33	13	int:BTRC
Interaction	FBP1 interactions	CIRBP HNRNPA0 U2AF1 LSM14A NCL SERBP1 ILF2 FUS FXR2 UBAP2L	1.35e-10	348	33	10	int:FBP1
Interaction	SRPK1 interactions	LARP1 U2AF1 ALYREF NCL TAF15 ILF2 FUS GAR1 RBM27 FBL CHTOP	1.41e-10	477	33	11	int:SRPK1
Interaction	HNRNPC interactions	HNRNPA0 LARP1 TRA2A TAF15 SERBP1 ILF2 FUS MBD2 FXR2 CCDC9 PAIP1 HNRNPR	1.64e-10	634	33	12	int:HNRNPC
Interaction	SMC5 interactions	HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS GAR1 RBM27 UBAP2L HNRNPR	1.70e-10	1000	33	14	int:SMC5
Interaction	EFTUD2 interactions	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS GAR1 FXR2 UBAP2L FBL HNRNPR	1.70e-10	1449	33	16	int:EFTUD2
Interaction	U2AF2 interactions	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL TAF15 SERBP1 ILF2 FBL CHTOP HNRNPR	2.23e-10	651	33	12	int:U2AF2
Interaction	EIF4A3 interactions	HNRNPA0 TRA2A ALYREF SERBP1 ILF2 FUS FMR1 FBL CCDC9 CHTOP HNRNPR	2.27e-10	499	33	11	int:EIF4A3
Interaction	DDX6 interactions	HNRNPA0 LARP1 LSM14A NCL FAM98A SERBP1 ILF2 FMR1 FXR2 UBAP2L HNRNPR	2.47e-10	503	33	11	int:DDX6
Interaction	DHX9 interactions	HNRNPA0 U2AF1 ALYREF LSM14A NCL TAF15 SERBP1 ILF2 FUS FMR1 MBD2 HNRNPR	2.70e-10	662	33	12	int:DHX9
Interaction	PCBP1 interactions	HNRNPA0 LSM14A NCL TAF15 SERBP1 ILF2 FUS FMR1 FXR2 UBAP2L FBL HNRNPR	3.15e-10	671	33	12	int:PCBP1
Interaction	SRSF3 interactions	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 NCL TAF15 ILF2 FUS CCDC9 HNRNPR	3.66e-10	522	33	11	int:SRSF3
Interaction	RNF2 interactions	CIRBP HNRNPA0 LARP1 TRA2A U2AF1 ALYREF NCL TAF15 GAR1 FXR2 FBL CHTOP HNRNPR	4.02e-10	866	33	13	int:RNF2
Interaction	MOV10 interactions	CIRBP HNRNPA0 LARP1 TRA2A AVEN LSM14A TAF15 SERBP1 ILF2 FUS FMR1 NFATC2IP FBL PAIP1 CHTOP	4.28e-10	1297	33	15	int:MOV10
Interaction	FMR1 interactions	CIRBP LARP1 LSM14A NCL SERBP1 ILF2 FMR1 FXR2 UBAP2L FBL CHTOP	4.85e-10	536	33	11	int:FMR1
Interaction	COPS5 interactions	CIRBP HNRNPA0 LARP1 TRA2A ALYREF NCL FAM98A TAF15 ILF2 FUS FBLL1 UBAP2L FBL HNRNPR	6.06e-10	1102	33	14	int:COPS5
Interaction	DDX21 interactions	HNRNPA0 LARP1 TRA2A ALYREF NCL TAF15 SERBP1 ILF2 FUS FBL CHTOP HNRNPR	6.81e-10	718	33	12	int:DDX21
Interaction	RPS16 interactions	HNRNPA0 LARP1 AVEN ALYREF NCL FAM98A SERBP1 ILF2 FMR1 FXR2 FBL HNRNPR	7.49e-10	724	33	12	int:RPS16
Interaction	CHMP4B interactions	NANOS3 HNRNPA0 TRA2A ALYREF NCL SERBP1 ILF2 FUS FBLL1 FXR2 FBL HNRNPR	7.85e-10	727	33	12	int:CHMP4B
Interaction	CNOT3 interactions	CIRBP NANOS3 LSM14A SERBP1 FMR1 FXR2 UBAP2L PAIP1	1.21e-09	207	33	8	int:CNOT3
Interaction	RBM45 interactions	HNRNPA0 LARP1 NCL ILF2 FUS FXR2 PAIP1 HNRNPR	1.21e-09	207	33	8	int:RBM45
Interaction	MIR138-1 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	1.21e-09	68	33	6	int:MIR138-1
Interaction	FUS interactions	HNRNPA0 LARP1 TRA2A ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS UBAP2L HNRNPR	1.24e-09	757	33	12	int:FUS
Interaction	SNRPC interactions	HNRNPA0 LARP1 TRA2A ALYREF TAF15 SERBP1 ILF2 FUS CHTOP HNRNPR	1.31e-09	440	33	10	int:SNRPC
Interaction	CUL2 interactions	CIRBP HNRNPA0 LARP1 ALYREF NCL FAM98A TAF15 SERBP1 ILF2 FUS HNRNPR	1.35e-09	591	33	11	int:CUL2
Interaction	RECQL4 interactions	CIRBP HNRNPA0 LARP1 U2AF1 ALYREF LSM14A NCL FAM98A SERBP1 ILF2 FUS GAR1 FBL CHTOP HNRNPR	1.39e-09	1412	33	15	int:RECQL4
Interaction	SOX2 interactions	HNRNPA0 LARP1 ALYREF LSM14A NCL FAM98A TAF15 SERBP1 ILF2 FUS MBD2 FBL AHDC1 CHTOP HNRNPR	1.53e-09	1422	33	15	int:SOX2
Interaction	MIR140 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	1.58e-09	71	33	6	int:MIR140
Interaction	CAPRIN1 interactions	CIRBP LARP1 LSM14A SERBP1 FUS FMR1 FXR2 UBAP2L FBL HNRNPR	1.67e-09	451	33	10	int:CAPRIN1
Interaction	HSF1 interactions	LARP1 TRA2A U2AF1 ALYREF NCL SERBP1 ILF2 FUS FBL CHTOP HNRNPR	1.86e-09	609	33	11	int:HSF1
Interaction	MIR18A interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	1.88e-09	73	33	6	int:MIR18A
Interaction	MIR29B1 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	1.88e-09	73	33	6	int:MIR29B1
Interaction	CEBPB interactions	HNRNPA0 LARP1 TRA2A U2AF1 ALYREF LSM14A NCL SERBP1 ILF2 MBD2 UBAP2L FBL CCDC9 CHTOP HNRNPR	1.88e-09	1443	33	15	int:CEBPB
Interaction	MIR20A interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	2.04e-09	74	33	6	int:MIR20A
Interaction	RBMX interactions	CIRBP HNRNPA0 LARP1 TRA2A TAF15 ILF2 FUS FXR2 PAIP1 HNRNPR	2.06e-09	461	33	10	int:RBMX
Interaction	RBM42 interactions	HNRNPA0 LARP1 ALYREF NCL SERBP1 ILF2 FMR1 FXR2 HNRNPR	2.13e-09	331	33	9	int:RBM42
Interaction	MIR15A interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	2.22e-09	75	33	6	int:MIR15A
Interaction	NFX1 interactions	CIRBP HNRNPA0 LARP1 ALYREF NCL FAM98A ILF2 FUS GAR1 FXR2	2.28e-09	466	33	10	int:NFX1
Interaction	LARP1B interactions	LARP1 TRA2A LSM14A SERBP1 ILF2 FBL PAIP1	2.35e-09	139	33	7	int:LARP1B
Interaction	MIR7-3 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	2.40e-09	76	33	6	int:MIR7-3
Interaction	MIR16-1 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	2.40e-09	76	33	6	int:MIR16-1
Interaction	MIR199A2 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	2.40e-09	76	33	6	int:MIR199A2
Interaction	MIR9-2 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	2.60e-09	77	33	6	int:MIR9-2
Interaction	RBM8A interactions	HNRNPA0 LARP1 AVEN ALYREF NCL SERBP1 ILF2 FMR1 CCDC9 CHTOP	2.63e-09	473	33	10	int:RBM8A
Interaction	SRSF5 interactions	HNRNPA0 LARP1 TRA2A U2AF1 NCL SERBP1 ILF2 FUS FBLL1 HNRNPR	2.69e-09	474	33	10	int:SRSF5
Interaction	MIR98 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	2.82e-09	78	33	6	int:MIR98
Interaction	MIR222 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	3.04e-09	79	33	6	int:MIR222
Interaction	MIR1-2 interactions	HNRNPA0 TRA2A FAM98A TAF15 FUS HNRNPR	3.04e-09	79	33	6	int:MIR1-2
Cytoband	1q21.3	ILF2 UBAP2L CHTOP	8.32e-05	117	33	3	1q21.3
Cytoband	19q13.1	KMT2B FBL	7.27e-04	55	33	2	19q13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	LSM14A PLEKHG2 KMT2B FBL CCDC9	1.52e-03	1192	33	5	chr19q13
Cytoband	Ensembl 112 genes in cytogenetic band chr1q21	ILF2 UBAP2L CHTOP	3.03e-03	404	33	3	chr1q21
GeneFamily	RNA binding motif containing	CIRBP HNRNPA0 TRA2A U2AF1 ALYREF NCL TAF15 FUS RBM27 HNRNPR	1.68e-15	213	18	10	725
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	TAF15 FUS	1.94e-04	21	18	2	89
Coexpression	HOUNKPE_HOUSEKEEPING_GENES	LARP1 U2AF1 LSM14A NCL FAM98A SERBP1 ILF2 NFATC2IP MBD2 FXR2 UBAP2L FBL PAIP1 CHTOP	2.66e-11	1129	33	14	M42508
Coexpression	HOUNKPE_HOUSEKEEPING_GENES	LARP1 U2AF1 LSM14A NCL FAM98A SERBP1 ILF2 NFATC2IP MBD2 FXR2 UBAP2L FBL PAIP1 CHTOP	3.72e-11	1158	33	14	MM1338
Coexpression	TABULA_MURIS_SENIS_LARGE_INTESTINE_SECRETORY_CELL_AGEING	CIRBP HNRNPA0 TRA2A SERBP1 FUS GAR1 MBD2 FBL PAIP1 CHTOP	1.44e-08	734	33	10	MM3740
Coexpression	PUJANA_ATM_PCC_NETWORK	TRA2A U2AF1 LSM14A NCL SERBP1 ILF2 FUS NFATC2IP MBD2 UBAP2L FBL HNRNPR	6.11e-08	1394	33	12	M9585
Coexpression	TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING	CIRBP U2AF1 ALYREF LSM14A NCL SERBP1 ILF2 FUS FBL CHTOP HNRNPR	8.33e-08	1144	33	11	MM3843
Coexpression	BOYLAN_MULTIPLE_MYELOMA_C_D_UP	TRA2A NCL FUS GAR1 UBAP2L	9.46e-07	143	33	5	M16927
Coexpression	BOYLAN_MULTIPLE_MYELOMA_C_D_UP	TRA2A NCL FUS GAR1 UBAP2L	9.46e-07	143	33	5	MM788
Coexpression	TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING	CIRBP HNRNPA0 TRA2A U2AF1 SERBP1 FUS KMT2B HNRNPR	1.63e-06	685	33	8	MM3782
Coexpression	MUELLER_PLURINET	U2AF1 NCL FUS GAR1 MBD2 FBL	1.79e-06	299	33	6	M123
Coexpression	GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN	HNRNPA0 LARP1 AVEN FUS CCDC9	4.79e-06	199	33	5	M7099
Coexpression	GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	ILF2 PLEKHG2 MBD2 RBM27 PAIP1	4.91e-06	200	33	5	M294
Coexpression	HALLMARK_MYC_TARGETS_V1	U2AF1 SERBP1 ILF2 FBL HNRNPR	4.91e-06	200	33	5	M5926
Coexpression	GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP	FAM98A SERBP1 GAR1 FXR2 HNRNPR	4.91e-06	200	33	5	M7805
Coexpression	TIEN_INTESTINE_PROBIOTICS_24HR_UP	HNRNPA0 FAM98A FUS NFATC2IP UBAP2L PAIP1 CHTOP	5.22e-06	561	33	7	M1463
Coexpression	TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING	CIRBP HNRNPA0 TRA2A NCL SERBP1 FUS KMT2B MBD2 CHTOP	5.54e-06	1088	33	9	MM3699
Coexpression	TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING	CIRBP HNRNPA0 TRA2A U2AF1 GAR1 FXR2 FBL	9.21e-06	612	33	7	MM3804
Coexpression	JOHNSTONE_PARVB_TARGETS_3_DN	TRA2A ALYREF LSM14A FAM98A FMR1 MBD2 CHTOP HNRNPR	1.00e-05	877	33	8	M2241
Coexpression	TABULA_MURIS_SENIS_THYMUS_THYMOCYTE_AGEING	CIRBP U2AF1 ALYREF NCL SERBP1 GAR1 FBL	2.21e-05	701	33	7	MM3849
Coexpression	SCHLOSSER_SERUM_RESPONSE_DN	HNRNPA0 TRA2A LSM14A FMR1 MBD2 PAIP1 HNRNPR	2.30e-05	705	33	7	M1410
Coexpression	PUJANA_CHEK2_PCC_NETWORK	U2AF1 NCL ILF2 NFATC2IP UBAP2L FBL HNRNPR	3.74e-05	761	33	7	M11961
Coexpression	TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING	CIRBP TRA2A U2AF1 ALYREF NCL FXR2 CHTOP HNRNPR	3.79e-05	1055	33	8	MM3677
Coexpression	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	SERBP1 ILF2 UBAP2L FBL CHTOP	4.05e-05	310	33	5	M10236
Coexpression	DODD_NASOPHARYNGEAL_CARCINOMA_UP	U2AF1 ALYREF NCL ILF2 FUS UBAP2L FBL PAIP1 CHTOP	4.31e-05	1407	33	9	M14427
Coexpression	GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	NCL SERBP1 ILF2 GAR1	1.05e-04	196	33	4	M3148
Coexpression	FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL	HNRNPA0 NCL SERBP1 ILF2 FBL	1.06e-04	380	33	5	M41703
Coexpression	TABULA_MURIS_SENIS_SKIN_EPIDERMAL_CELL_AGEING	CIRBP TRA2A U2AF1 SERBP1 GAR1 FBL	1.08e-04	618	33	6	MM3829
Coexpression	GSE36826_WT_VS_IL1R_KO_SKIN_DN	TRA2A ILF2 CHTOP HNRNPR	1.09e-04	198	33	4	M9530
Coexpression	GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP	NCL SERBP1 FUS GAR1	1.11e-04	199	33	4	M8863
Coexpression	GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN	LSM14A FUS MBD2 UBAP2L	1.13e-04	200	33	4	M8854
Coexpression	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	HNRNPA0 FAM98A SERBP1 ILF2	1.13e-04	200	33	4	M6065
Coexpression	GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN	CIRBP LARP1 ILF2 FMR1	1.13e-04	200	33	4	M7436
Coexpression	GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP	HNRNPA0 ILF2 FMR1 RBM27	1.13e-04	200	33	4	M5668
Coexpression	TABULA_MURIS_SENIS_SKIN_BULGE_KERATINOCYTE_AGEING	CIRBP HNRNPA0 TRA2A U2AF1 NCL SERBP1 FBL	1.19e-04	915	33	7	MM3828
Coexpression	BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS	NCL FBL HNRNPR	1.35e-04	79	33	3	M40003
Coexpression	TABULA_MURIS_SENIS_LARGE_INTESTINE_INTESTINAL_CRYPT_STEM_CELL_AGEING	CIRBP U2AF1 SERBP1 GAR1 FBL	1.40e-04	403	33	5	MM3738
Coexpression	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	CIRBP LSM14A TAF15 SERBP1 FUS CHTOP	1.66e-04	669	33	6	M18635
Coexpression	LAIHO_COLORECTAL_CANCER_SERRATED_DN	FMR1 NFATC2IP CCDC9	1.67e-04	85	33	3	M17423
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	CIRBP TRA2A U2AF1 FUS UBAP2L	1.93e-04	432	33	5	M41149
Coexpression	GARY_CD5_TARGETS_DN	FAM98A SERBP1 FMR1 GAR1 UBAP2L	2.10e-04	440	33	5	M13893
Coexpression	DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	NCL ILF2 UBAP2L FBL	2.35e-04	242	33	4	M34034
Coexpression	TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING	CIRBP HNRNPA0 TRA2A SERBP1 FUS KMT2B	2.47e-04	720	33	6	MM3700
Coexpression	TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_STEM_CELL_AGEING	CIRBP U2AF1 SERBP1 KMT2B GAR1 FBL	2.49e-04	721	33	6	MM3800
Coexpression	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	ALYREF NCL FAM98A SERBP1 GAR1 UBAP2L FBL	2.70e-04	1045	33	7	M8525
Coexpression	BENPORATH_SOX2_TARGETS	TRA2A AVEN FAM98A TAF15 ILF2 FUS	2.74e-04	734	33	6	M3835
Coexpression	LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB	CIRBP NCL SERBP1 HNRNPR	3.46e-04	268	33	4	M39228
Coexpression	LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB	CIRBP NCL SERBP1 HNRNPR	3.98e-04	278	33	4	M39227
Coexpression	COLLER_MYC_TARGETS_UP	NCL FBL	4.17e-04	24	33	2	M5955
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_OLIGODENDROCYTE_AGEING	CIRBP U2AF1 NCL SERBP1 FUS PAIP1 HNRNPR	4.55e-04	1139	33	7	MM3690
Coexpression	GENTILE_UV_HIGH_DOSE_DN	LSM14A MBD2 AHDC1 CHTOP	4.60e-04	289	33	4	M13630
Coexpression	TABULA_MURIS_SENIS_PANCREAS_ENDOTHELIAL_CELL_AGEING	HNRNPA0 TRA2A FUS FMR1	5.36e-04	301	33	4	MM3813
Coexpression	BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS	NCL SERBP1 FBL HNRNPR	5.64e-04	305	33	4	M40025
Coexpression	RUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS	CIRBP HNRNPA0 U2AF1 HNRNPR	5.99e-04	310	33	4	M41748
Coexpression	BUSSLINGER_DUODENAL_STEM_CELLS	U2AF1 NCL SERBP1 FBL	6.06e-04	311	33	4	M40024
Coexpression	TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MYELOID_CELL_AGEING	HNRNPA0 TRA2A SERBP1 KMT2B	7.07e-04	324	33	4	MM3701
Coexpression	LEE_BMP2_TARGETS_DN	LARP1 TRA2A FAM98A ILF2 GAR1 NFATC2IP	8.26e-04	904	33	6	M2325
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	LARP1 TAF15 FXR2 UBAP2L	8.27e-04	338	33	4	M17094
Coexpression	GENTILE_UV_RESPONSE_CLUSTER_D6	AHDC1 CHTOP	8.91e-04	35	33	2	M15187
Coexpression	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	PLEKHG2 FBL	8.91e-04	35	33	2	M14529
Coexpression	LEE_BMP2_TARGETS_DN	LARP1 TRA2A FAM98A ILF2 GAR1 NFATC2IP	9.15e-04	922	33	6	MM1068
Coexpression	CAIRO_HEPATOBLASTOMA_CLASSES_UP	NCL SERBP1 ILF2 FBL HNRNPR	9.43e-04	612	33	5	M4772
Coexpression	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	ALYREF NCL FAM98A SERBP1 GAR1 UBAP2L	1.07e-03	950	33	6	M19907
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING	CIRBP U2AF1 GAR1 FXR2 FBL CCDC9	1.09e-03	954	33	6	MM3689
Coexpression	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	FAM98A PLEKHG2 CHTOP	1.10e-03	162	33	3	M6387
Coexpression	GSE6269_FLU_VS_E_COLI_INF_PBMC_UP	LARP1 KMT2B NFATC2IP	1.14e-03	164	33	3	M5653
Coexpression	GAUTAM_EYE_CORNEA_FIBROBLASTS	NCL FUS FBL	1.16e-03	165	33	3	M43617
Coexpression	GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP	CIRBP FUS GAR1	1.31e-03	172	33	3	M2963
Coexpression	WANG_TUMOR_INVASIVENESS_UP	CIRBP NCL SERBP1 HNRNPR	1.33e-03	384	33	4	M1865
Coexpression	GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN	LARP1 SERBP1 FXR2	1.42e-03	177	33	3	M394
Coexpression	TABULA_MURIS_SENIS_SKIN_BASAL_CELL_OF_EPIDERMIS_AGEING	CIRBP U2AF1 SERBP1 GAR1 FXR2 FBL	1.43e-03	1005	33	6	MM3827
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	HNRNPA0 LARP1 PLEKHG2	1.49e-03	180	33	3	M9145
Coexpression	HSIAO_HOUSEKEEPING_GENES	CIRBP NCL FUS FBL	1.50e-03	397	33	4	M11197
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	HNRNPA0 FUS NFATC2IP UBAP2L	1.53e-03	399	33	4	M41172
Coexpression	DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP	HNRNPA0 LARP1 TRA2A ILF2 GAR1 PAIP1 HNRNPR	1.53e-03	1399	33	7	M535
Coexpression	WANG_TUMOR_INVASIVENESS_UP	CIRBP NCL SERBP1 HNRNPR	1.57e-03	402	33	4	MM1248
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	LARP1 TRA2A CHTOP	1.59e-03	184	33	3	M19988
Coexpression	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	NCL FBL	1.67e-03	48	33	2	M2138
Coexpression	GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	NFATC2IP MBD2 CHTOP	1.77e-03	191	33	3	M7130
Coexpression	GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN	TRA2A ALYREF GAR1	1.82e-03	193	33	3	M3137
Coexpression	GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN	AVEN NCL GAR1	1.90e-03	196	33	3	M10002
Coexpression	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP	AVEN ILF2 CCDC9	1.93e-03	197	33	3	M7939
Coexpression	GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP	ILF2 CHTOP HNRNPR	1.96e-03	198	33	3	M9534
Coexpression	GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN	DPP6 GAR1 FBL	1.99e-03	199	33	3	M8197
Coexpression	GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN	AVEN SERBP1 BRWD3	1.99e-03	199	33	3	M7782
Coexpression	GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP	LARP1 DPP6 FBL	1.99e-03	199	33	3	M3262
Coexpression	GSE17721_0.5H_VS_8H_CPG_BMDC_DN	TRA2A FMR1 MBD2	1.99e-03	199	33	3	M4127
Coexpression	GSE3982_MAST_CELL_VS_DC_UP	CIRBP TRA2A ILF2	1.99e-03	199	33	3	M5426
Coexpression	GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN	CIRBP LSM14A NFATC2IP	1.99e-03	199	33	3	M8313
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN	HNRNPA0 TRA2A TAF15	1.99e-03	199	33	3	M4407
Coexpression	GSE360_CTRL_VS_L_DONOVANI_MAC_DN	FAM98A FMR1 NFATC2IP	1.99e-03	199	33	3	M5159
Coexpression	GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN	HNRNPA0 ILF2 MBD2	1.99e-03	199	33	3	M8770
Coexpression	GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP	LSM14A PLEKHG2 NFATC2IP	1.99e-03	199	33	3	M5620
Coexpression	GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN	HNRNPA0 DPP6 MBD2	1.99e-03	199	33	3	M4310
Coexpression	SHEN_SMARCA2_TARGETS_UP	LSM14A FMR1 PAIP1 CHTOP	1.99e-03	429	33	4	M29
Coexpression	GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN	FXR2 CHTOP BRWD3	2.02e-03	200	33	3	M3747
Coexpression	GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP	AVEN NCL FAM98A	2.02e-03	200	33	3	M4613
Coexpression	GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP	AVEN ILF2 NFATC2IP	2.02e-03	200	33	3	M4601
Coexpression	GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP	U2AF1 NCL GAR1	2.02e-03	200	33	3	M9877
Coexpression	GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN	LARP1 AVEN ILF2	2.02e-03	200	33	3	M5094
Coexpression	GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP	FMR1 MBD2 CHTOP	2.02e-03	200	33	3	M9075
Coexpression	GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP	HNRNPA0 FMR1 CHTOP	2.02e-03	200	33	3	M3316
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000	NCL FUS FXR2 UBAP2L AHDC1 HNRNPR	1.87e-05	378	32	6	gudmap_developingGonad_e16.5_testes_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	LSM14A NCL FAM98A TAF15 SERBP1 PLEKHG2	6.26e-05	469	32	6	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	facebase_RNAseq_e9.5_MandArch_2500_K3	AVEN ALYREF NCL TAF15 FMR1 NFATC2IP FXR2 FBL AHDC1	7.12e-05	1259	32	9	facebase_RNAseq_e9.5_MandArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	TRA2A NCL FAM98A TAF15 SERBP1 RBM27	1.25e-04	532	32	6	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000	NANOS3 AVEN FMR1 GAR1 NFATC2IP RBM27 FXR2	1.54e-04	799	32	7	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500	NCL FUS UBAP2L HNRNPR	3.86e-04	231	32	4	gudmap_developingGonad_e11.5_testes and mesonephros_k4_500
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 TAF15 ILF2 FUS AHDC1 HNRNPR	6.96e-09	199	33	6	5478b78349b5d8d57f30bb650dcbd5fdb84283d6
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CIRBP ILF2 FUS UBAP2L HNRNPR	5.20e-08	136	33	5	3e13dc0634f3b05e9f9e6c3193f843f62e603b78
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CIRBP ILF2 FUS UBAP2L HNRNPR	5.20e-08	136	33	5	0185486c39700dd2f72d79be6d283494dd8379c9
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	U2AF1 NCL ILF2 FUS CHTOP	9.99e-08	155	33	5	9d53caee196b5c2bbc90c4f54f693b64d4086065
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ALYREF ILF2 PAIP1 CHTOP HNRNPR	2.61e-07	188	33	5	8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc
ToppCell	10x_3'_v3\|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HNRNPA0 SERBP1 FUS MBD2 HNRNPR	3.37e-07	198	33	5	aabb8e9b162ae4cb26ea860c99decdbb51e379e1
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	NCL ILF2 FUS FBL HNRNPR	3.45e-07	199	33	5	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	NCL ILF2 GAR1 FBL HNRNPR	3.45e-07	199	33	5	6f159c1215439ec22374903124085746fa8da333
ToppCell	facs-Tongue-nan-24m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCL SERBP1 GAR1 FBL	7.22e-06	169	33	4	0054f9bfd4d377c7fd94873c1308622051c59a8e
ToppCell	facs-Bladder-nan-24m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIRBP U2AF1 NCL GAR1	9.06e-06	179	33	4	fc9f44fb81da0d381a5141a95a005e66a0be28cc
ToppCell	facs-Bladder-nan-24m\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIRBP U2AF1 NCL GAR1	9.06e-06	179	33	4	9152d92bb96e65d43de54e933494f0d08ae02c4f
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5\|Striatum / BrainAtlas - Mouse McCarroll V32	U2AF1 ALYREF ILF2 FUS	9.88e-06	183	33	4	f20b0d71f857ac35868fd80531050ad8b6091716
ToppCell	facs-Thymus-Flowthrough-24m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALYREF NCL SERBP1 FBL	1.05e-05	186	33	4	202e1514954a5a654f7588bed72cd12db513bb19
ToppCell	E12.5\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	U2AF1 NCL ILF2 FBL	1.24e-05	194	33	4	4b335e4da58de1cd94194dc4208ce83854e5e50a
ToppCell	10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NCL SERBP1 GAR1 FBL	1.24e-05	194	33	4	7ad255fa357d41fe57ed803314de46a6577a1283
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	U2AF1 GAR1 FBL PAIP1	1.27e-05	195	33	4	f4f53fcfcce9d4337e09f1f8582a9c813ed40c35
ToppCell	C_03\|World / shred on cell type and cluster	HNRNPA0 SERBP1 ILF2 FBL	1.37e-05	199	33	4	1ae1c7152a49a5484e715a1e084f6e02bdbcaca3
ToppCell	10x5'v1-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 TAF15 ILF2 HNRNPR	1.37e-05	199	33	4	713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 TAF15 ILF2 HNRNPR	1.37e-05	199	33	4	ea75804c34989c99aab542e6d72617ed144819b6
ToppCell	myeloid-Dendritic_cell\|myeloid / Lineage, cell class and subclass	HNRNPA0 SERBP1 ILF2 FBL	1.37e-05	199	33	4	b81c0a40481f1006ac4aa8759af95448cb5fc2e6
ToppCell	HSPCs\|World / Lineage and Cell class	NCL SERBP1 GAR1 FBL	1.37e-05	199	33	4	df1ffc416c6946f1ba182f242a50ee41a571d565
ToppCell	myeloid-Dendritic_cell-Conventional_dendritic_cell\|myeloid / Lineage, cell class and subclass	HNRNPA0 SERBP1 ILF2 FBL	1.37e-05	199	33	4	1e7ce1a1d6a7af18351d64b7a5334efa6dd9abc5
ToppCell	Healthy/Control\|World / Disease group and Cell class	CIRBP HNRNPA0 NCL FUS	1.37e-05	199	33	4	2623c42b3e79e401a485879b52e8bbcbc581544d
ToppCell	pdx-Tumor_cells-T4\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ALYREF NCL FBL	1.91e-04	152	33	3	7ccc56b79c499dd48dab8e2d936edca5223b9356
ToppCell	facs-Tongue-nan-24m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCL SERBP1 GAR1	2.52e-04	167	33	3	73fdf4b81a45ec686d2929eaf641b434f70b7898
ToppCell	facs-Tongue-nan-24m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCL SERBP1 GAR1	2.52e-04	167	33	3	c4157fb31b44fe7c44be4215dda8ae2d37cf49a8
ToppCell	facs-Spleen-nan-24m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIRBP HNRNPA0 SERBP1	2.52e-04	167	33	3	9a8e291c082d7c26bab21df77bd36ce927032a70
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AVEN MBD2 CCDC9	2.80e-04	173	33	3	20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ILF2 FUS HNRNPR	3.15e-04	180	33	3	44988c34861df359a68376500c42a64fbcc4b431
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRA2A SERBP1 PLEKHG2	3.25e-04	182	33	3	ab78df9de3878a6d67106a40094c893601de8076
ToppCell	facs-Bladder-nan-24m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIRBP U2AF1 NCL	3.30e-04	183	33	3	268fc48ffd88e19c9dcd1af32b635256fc915742
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	U2AF1 NCL FBL	3.30e-04	183	33	3	523896bd1a93bdda81a009768baa3a1bdbd108b8
ToppCell	PBMC-Mild-cDC_8\|Mild / Compartment, Disease Groups and Clusters	HNRNPA0 PLEKHG2 MBD2	3.41e-04	185	33	3	891b39c20fe9858fbba90d9ef7a253f1a0870211
ToppCell	facs-Bladder-nan-24m-Epithelial-bladder_urothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIRBP U2AF1 NCL	3.46e-04	186	33	3	8589d55f7f778442bf31cd4eb1fdaa632f1b7ab0
ToppCell	facs-Thymus-Flowthrough-24m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALYREF NCL SERBP1	3.52e-04	187	33	3	376a95ac1e38f61f8db5d23d9a905f8dae8c40b6
ToppCell	(02)_Cycling_Basal_(regeneration)-(1)_24hpi\|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint	ALYREF SERBP1 FBL	3.63e-04	189	33	3	311f3aed469be3c8ff913dcc5a2442daa8446d55
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	U2AF1 ILF2 FBL	3.63e-04	189	33	3	be09a116ce0ea9ddfa0974806c6f805438e44660
ToppCell	Striatum-Macroglia-POLYDENDROCYTE\|Striatum / BrainAtlas - Mouse McCarroll V32	U2AF1 ALYREF ILF2	3.74e-04	191	33	3	6bc9c7c86040f3ebce08c350e625e345581d4550
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ALYREF NCL MBD2	3.74e-04	191	33	3	0f9443da0f73d07456142fae08b2dc92a5b7b592
ToppCell	3'_v3-Lung-Lymphocytic_NK-NK_CD56bright_CD16-\|Lung / Manually curated celltypes from each tissue	CIRBP NCL FUS	3.74e-04	191	33	3	12ce360dc149c85d5a22cfc1bf53d54aef79edc1
ToppCell	10x3'2.3-week_12-13-Hematopoietic-erythroid-early_erythroid\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SERBP1 GAR1 FBL	3.80e-04	192	33	3	f29d3d5223fccec3e34ab6582e9503adb14be543
ToppCell	E15.5\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NCL SERBP1 FBL	3.80e-04	192	33	3	4a0fb4ef8a9281489ffb0881421c9d691c52019c
ToppCell	PBMC-Control-cDC_6\|Control / Compartment, Disease Groups and Clusters	HNRNPA0 NCL FUS	3.80e-04	192	33	3	41a7201febb7d88a39e4ee64df04cce18c691df8
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCL GAR1 FBL	3.80e-04	192	33	3	448b71c965e1b7addc6bccbcd6047cefda3d5b5a
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCL GAR1 FBL	3.80e-04	192	33	3	5155f746ad57122ef735da776c96721005b8dadc
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CIRBP NCL FUS	3.86e-04	193	33	3	739fb2a57772a800a2e94bdd6c71285bb2c162a7
ToppCell	PBMC-Severe-cDC_5\|Severe / Compartment, Disease Groups and Clusters	CIRBP ALYREF MBD2	3.92e-04	194	33	3	b903e23eb75733ca516770727097fe74a9f8c1d1
ToppCell	facs-Skin-Skin_Anagen-18m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRA2A U2AF1 KMT2B	3.97e-04	195	33	3	0d37dd66a8d60fc9cda3d6e3c4fbe67e577b890e
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRA2A U2AF1 KMT2B	3.97e-04	195	33	3	2c03d1a2f208b6737311458a4bd8f2e4444de29a
ToppCell	CV-Severe-2\|CV / Virus stimulation, Condition and Cluster	NCL SERBP1 FBL	3.97e-04	195	33	3	1cde7f6e6c9c610bacc79014519447112c27dd9d
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	U2AF1 ILF2 FBL	3.97e-04	195	33	3	44ac99e33b20a377009b8fef16142050a3e1da51
ToppCell	mild_COVID-19\|World / disease group, cell group and cell class (v2)	CIRBP HNRNPA0 FUS	3.97e-04	195	33	3	6dbe9db5f0e94f2e91b3d1282855d200051ab0ba
ToppCell	facs-Skin-Skin_Anagen\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRA2A U2AF1 KMT2B	3.97e-04	195	33	3	ffd87cc7ae9b141bf48e072ea1a1420794499790
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.03e-04	196	33	3	6ba02b806d440eed45bad7616bf3b8be57034427
ToppCell	Megakaryocytic-erythropoietic-MEP\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	HNRNPA0 FUS FBL	4.03e-04	196	33	3	f90e7fe3a7b2fff30d01a25cc500876861c2e4f1
ToppCell	Megakaryocytic-erythropoietic-MEP-MEP\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	HNRNPA0 FUS FBL	4.03e-04	196	33	3	4e97010185fa9392da8f69e7b2a7395bf063f8ff
ToppCell	control-Others-CD34+_GATA2+_cells\|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NCL ILF2 FBL	4.03e-04	196	33	3	25994ca143701c72d2f84a3b6d348fcfa1d26a54
ToppCell	10x5'v1-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 TAF15 ILF2	4.03e-04	196	33	3	31229affb48521e8be93b6061178fd8cea09ba99
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CIRBP HNRNPA0 FUS	4.09e-04	197	33	3	9af431323da6d099459b7360af40e5df998cffbd
ToppCell	NS-critical-d_16-33-Lymphoid\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CIRBP HNRNPA0 FBL	4.09e-04	197	33	3	c6c33f8e2cfd4c6853e77bc3ad334ae41069758c
ToppCell	normal\|World / PBMC cell types (v2) per disease, treatment status, and sex	CIRBP NCL FBL	4.09e-04	197	33	3	232e48864aeb5ad6688352383427fb1771986ddc
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.16e-04	198	33	3	8aa4149d2c1cec73cfd654db093252ec8ec5ef68
ToppCell	Healthy_donor\|World / disease group, cell group and cell class (v2)	CIRBP NCL FUS	4.16e-04	198	33	3	1ed0b50c9754727a05c27b21f3546bf2e37eef7f
ToppCell	10x5'v1-week_14-16-Hematopoietic-erythroid-early_erythroid\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NCL SERBP1 GAR1	4.16e-04	198	33	3	bcdbba72bd2004a2863635b150abd671265e3ed9
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HNRNPA0 ILF2 HNRNPR	4.16e-04	198	33	3	cd876fba12ff30b74aa507286cb1f3a867011a92
ToppCell	myeloid-cDC\|myeloid / Lineage and Cell class	HNRNPA0 SERBP1 FBL	4.16e-04	198	33	3	a751cc63bc6314f57fef4cd2a36a84b23b379fa0
ToppCell	10x3'2.3-week_14-16-Hematopoietic-erythroid-early_erythroid\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SERBP1 GAR1 FBL	4.16e-04	198	33	3	36c848b747903ff875ebb241eefbcd889f39be29
ToppCell	CV-Moderate-2\|Moderate / Virus stimulation, Condition and Cluster	NCL SERBP1 FBL	4.22e-04	199	33	3	70d6f2a328eec4cb2cecb7cd85859fba9e15c9c8
ToppCell	3'-GW_trimst-1\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CIRBP HNRNPA0 ILF2	4.22e-04	199	33	3	ecfb6381e2971a3e355e661a6df0021914485e74
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.22e-04	199	33	3	8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.22e-04	199	33	3	fe3b7d540a644dfc6beea171c809b4d1ba4e188f
ToppCell	Enterocyte_Progenitors\|World / shred on cell type and cluster	SERBP1 FUS FBL	4.22e-04	199	33	3	776bcc887927dea9ebd76ec4338ce2225c319c2c
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.22e-04	199	33	3	8daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.22e-04	199	33	3	cdee798e3586e4e7a15de598239090a85752ea1e
ToppCell	CD8+_Memory_T_cell-CV-2\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	NCL SERBP1 FBL	4.22e-04	199	33	3	1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.22e-04	199	33	3	be425e9cb90a73289026b1b7cb581e1c02a8985e
ToppCell	NS-critical-LOC-Lymphoid\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CIRBP HNRNPA0 FBL	4.22e-04	199	33	3	e2d0346cc0c45253b1f958e11263f45e09fd38cb
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.22e-04	199	33	3	99778178e3ec121802db938db8c5475d19b43fec
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.28e-04	200	33	3	0fd9a8730b7dc461ddf4586899d363541e72d8ba
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	NCL ILF2 FUS	4.28e-04	200	33	3	ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc
ToppCell	TCGA-Bile_Duct-Primary_Tumor\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	NCL ILF2 FUS	4.28e-04	200	33	3	0350e5ffd36033099b7e32a1fdd790fff99790dc
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.28e-04	200	33	3	c28d4ca51d2e2a3a22784ee251975f16a55b0297
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Radial_glial-RG\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	NCL SERBP1 FBL	4.28e-04	200	33	3	b3775715b66aee18cff469bf3dbe9c305671c6d6
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma\|TCGA-Liver / Sample_Type by Project: Shred V9	ILF2 UBAP2L CHTOP	4.28e-04	200	33	3	9cff8be6e566f342fc8b45e93106d033b14759ee
ToppCell	Brain_organoid-organoid_Tanaka_cellReport\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	U2AF1 NCL RBM27	4.28e-04	200	33	3	b0ba486b55be18a4236bd2644f02352651f4b1fe
ToppCell	Sepsis-Bac-SEP\|Sepsis / Disease, condition lineage and cell class	CIRBP HNRNPA0 FUS	4.28e-04	200	33	3	1f80e6a49c632b3ba0cdac1225c78e5d6d6d78a5
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	NCL SERBP1 MBD2	4.28e-04	200	33	3	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	10x5'v1-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.28e-04	200	33	3	364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Radial_glial\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	NCL SERBP1 FBL	4.28e-04	200	33	3	9069e8d3bcc5f44baa00f2abb6cffd87586c3eab
ToppCell	TCGA-Liver-Primary_Tumor\|TCGA-Liver / Sample_Type by Project: Shred V9	ILF2 UBAP2L CHTOP	4.28e-04	200	33	3	b667168081393433597f6ca8baeddba1d1906d40
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 ILF2 HNRNPR	4.28e-04	200	33	3	19a4213f180ac2d29625d140b602a93a74ab3fdd
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	PLEKHG2 CHTOP	1.92e-03	88	33	2	142d2e00ef19c0ad011a21945bf1111271056eae
Computational	Neighborhood of APEX1	U2AF1 NCL SERBP1 ILF2 FUS FBL HNRNPR	1.13e-09	92	25	7	GNF2_APEX1
Computational	Genes in the cancer module 32.	CIRBP HNRNPA0 U2AF1 NCL ILF2 FUS FMR1 FBL HNRNPR	1.84e-09	241	25	9	MODULE_32
Computational	Neighborhood of BUB3	U2AF1 NCL SERBP1 ILF2 FUS UBAP2L FBL HNRNPR	1.30e-07	277	25	8	MORF_BUB3
Computational	Neighborhood of FBL	U2AF1 NCL SERBP1 ILF2 FUS FBL	6.33e-07	140	25	6	MORF_FBL
Computational	Neighborhood of RAD23A	LARP1 U2AF1 NCL ILF2 FUS UBAP2L FBL HNRNPR	7.44e-07	348	25	8	MORF_RAD23A
Computational	Neighborhood of EIF3S2	U2AF1 NCL SERBP1 ILF2 FUS FBL HNRNPR	1.02e-06	246	25	7	MORF_EIF3S2
Computational	Neighborhood of DEK	HNRNPA0 U2AF1 NCL ILF2 FUS FBL HNRNPR	1.64e-06	264	25	7	MORF_DEK
Computational	Neighborhood of ACP1	U2AF1 LSM14A NCL ILF2 FUS HNRNPR	6.91e-06	211	25	6	MORF_ACP1
Computational	Neighborhood of UBE2I	U2AF1 LSM14A NCL ILF2 FUS FBL	1.38e-05	238	25	6	MORF_UBE2I
Computational	Neighborhood of TERF1	U2AF1 ILF2 FUS HNRNPR	1.58e-05	67	25	4	MORF_TERF1
Computational	Neighborhood of NPM1	NCL SERBP1 FBL HNRNPR	2.10e-05	72	25	4	GNF2_NPM1
Computational	Neighborhood of SOD1	LARP1 U2AF1 ILF2 FUS UBAP2L FBL	3.32e-05	278	25	6	MORF_SOD1
Computational	Neighborhood of PCNA	U2AF1 NCL FUS FBL	3.70e-05	83	25	4	MORF_PCNA
Computational	Neighborhood of G22P1	U2AF1 NCL ILF2 FUS FBL	4.06e-05	172	25	5	MORF_G22P1
Computational	Neighborhood of UBE2N	U2AF1 FUS UBAP2L HNRNPR	6.28e-05	95	25	4	MORF_UBE2N
Computational	Neighborhood of TDG	NCL SERBP1 HNRNPR	6.93e-05	35	25	3	GNF2_TDG
Computational	Neighborhood of ANP32B	U2AF1 NCL ILF2	7.54e-05	36	25	3	GCM_ANP32B
Computational	Neighborhood of MLH1	NCL SERBP1 ILF2	1.20e-04	42	25	3	GNF2_MLH1
Computational	Neighborhood of XRCC5	U2AF1 NCL ILF2 FUS HNRNPR	1.78e-04	235	25	5	MORF_XRCC5
Computational	Genes in the cancer module 98.	HNRNPA0 ILF2 FUS FXR2 FBL HNRNPR	2.25e-04	393	25	6	MODULE_98
Computational	Neighborhood of DEK	NCL SERBP1 HNRNPR	3.15e-04	58	25	3	GNF2_DEK
Computational	Neighborhood of RAN	U2AF1 NCL ILF2 FUS FBL	3.27e-04	268	25	5	MORF_RAN
Computational	Neighborhood of SNRP70	U2AF1 LSM14A NCL	3.84e-04	62	25	3	MORF_SNRP70
Computational	Neighborhood of HDAC2	U2AF1 SERBP1 ILF2 FUS HNRNPR	4.01e-04	280	25	5	MORF_HDAC2
Computational	Neighborhood of SART1	U2AF1 LSM14A NCL	4.03e-04	63	25	3	MORF_SART1
Computational	RNA splicing.	HNRNPA0 U2AF1 HNRNPR	4.41e-04	65	25	3	MODULE_183
Computational	Neighborhood of CSNK2B	LARP1 U2AF1 FUS UBAP2L FBL	4.49e-04	287	25	5	MORF_CSNK2B
Computational	Neighborhood of GNB1	U2AF1 NCL ILF2 FUS HNRNPR	5.93e-04	305	25	5	MORF_GNB1
Computational	Neighborhood of CDK2	U2AF1 ILF2 FUS	5.96e-04	72	25	3	MORF_CDK2
Computational	Neighborhood of MYST2	AHDC1 PAIP1 CHTOP HNRNPR	6.16e-04	172	25	4	GCM_MYST2
Computational	Neighborhood of KPNB1	NCL FBL HNRNPR	6.21e-04	73	25	3	GNF2_KPNB1
Computational	Neighborhood of HAT1	U2AF1 FUS UBAP2L HNRNPR	6.57e-04	175	25	4	MORF_HAT1
Computational	Neighborhood of ANP32B	U2AF1 NCL FUS FBL	1.04e-03	198	25	4	MORF_ANP32B
Computational	Neighborhood of AATF	NCL SERBP1 ILF2 FUS	1.27e-03	209	25	4	MORF_AATF
Computational	Neighborhood of CSNK2B	NCL ILF2 FUS	1.50e-03	99	25	3	GCM_CSNK2B
Computational	Neighborhood of HDAC1	TRA2A FBL HNRNPR	2.04e-03	110	25	3	GNF2_HDAC1
Computational	Neighborhood of MAX	LSM14A HNRNPR	2.32e-03	31	25	2	GCM_MAX
Computational	Neighborhood of HDAC1	U2AF1 NCL FUS HNRNPR	2.60e-03	254	25	4	MORF_HDAC1
Computational	Neighborhood of EIF3S6	U2AF1 NCL FBL	2.73e-03	122	25	3	MORF_EIF3S6
Computational	Neighborhood of ACTG1	U2AF1 NCL ILF2	2.86e-03	124	25	3	GCM_ACTG1
Computational	Neighborhood of NCAM1	AHDC1 PAIP1 CHTOP	3.06e-03	127	25	3	GCM_NCAM1
Computational	Neighborhood of CSNK1A1	SERBP1 CHTOP	3.12e-03	36	25	2	GCM_CSNK1A1
Computational	Neighborhood of G22P1	U2AF1 ILF2	3.12e-03	36	25	2	GNF2_G22P1
Computational	Neighborhood of PPP2CA	U2AF1 NCL ILF2	3.20e-03	129	25	3	MORF_PPP2CA
Computational	Neighborhood of RAD21	NCL ILF2	3.29e-03	37	25	2	GCM_RAD21
Computational	Neighborhood of ANP32B	SERBP1 GAR1	3.29e-03	37	25	2	GNF2_ANP32B
Computational	Neighborhood of HDAC1	NCL ILF2	3.47e-03	38	25	2	GCM_HDAC1
Computational	Neighborhood of EIF4A2	LSM14A NCL ILF2	3.87e-03	138	25	3	MORF_EIF4A2
Computational	Neighborhood of RAF1	ILF2 FUS	4.42e-03	43	25	2	GCM_RAF1
Computational	Neighborhood of FBL	NCL FBL HNRNPR	4.54e-03	146	25	3	GNF2_FBL
Computational	Neighborhood of UBE2I	U2AF1 FBL	4.63e-03	44	25	2	GNF2_UBE2I
Computational	Genes in the cancer module 198.	HNRNPA0 ILF2 FUS HNRNPR	4.90e-03	303	25	4	MODULE_198
Computational	Neighborhood of ELAC2	FUS HNRNPR	5.05e-03	46	25	2	GNF2_ELAC2
Computational	Neighborhood of UBE2N	AHDC1 CHTOP HNRNPR	5.26e-03	154	25	3	GCM_UBE2N
Computational	Neighborhood of GSPT1	LARP1 UBAP2L	5.71e-03	49	25	2	MORF_GSPT1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ILF2 FBL	5.94e-03	50	25	2	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_GLYCOLYSIS_MYC
Computational	Neighborhood of DENR	FUS HNRNPR	6.18e-03	51	25	2	GNF2_DENR
Computational	Neighborhood of PFN1	NCL ILF2	6.18e-03	51	25	2	GCM_PFN1
Computational	Neighborhood of PPP1CC	NCL ILF2	7.41e-03	56	25	2	GCM_PPP1CC
Computational	Neighborhood of RAD21	U2AF1 ILF2 UBAP2L	8.10e-03	180	25	3	MORF_RAD21
Computational	Neighborhood of SMC1L1	NCL HNRNPR	9.02e-03	62	25	2	MORF_SMC1L1
Computational	Neighborhood of DDX5	NCL FUS	9.88e-03	65	25	2	GCM_DDX5
Computational	Neighborhood of BECN1	FUS UBAP2L	1.08e-02	68	25	2	GCM_BECN1
Computational	Neighborhood of CBFB	NCL ILF2	1.14e-02	70	25	2	GCM_CBFB
Computational	Neighborhood of HBP1	CHTOP HNRNPR	1.14e-02	70	25	2	GCM_HBP1
Computational	Neighborhood of RBBP6	FUS FBL	1.14e-02	70	25	2	GNF2_RBBP6
Computational	Neighborhood of XRCC5	NCL ILF2	1.30e-02	75	25	2	GNF2_XRCC5
Computational	Neighborhood of PA2G4	NCL SERBP1	1.43e-02	79	25	2	GNF2_PA2G4
Drug	U1-6	NCL FBLL1 GAR1 FBL	5.22e-07	45	33	4	CID006914648
Drug	DB08668	NCL FBLL1 GAR1 FBL	2.33e-06	65	33	4	CID011840990
Drug	U-17	NCL FBLL1 GAR1 FBL	2.47e-06	66	33	4	CID011840991
Drug	AC1L1AVT	NCL FBLL1 FBL	4.82e-06	23	33	3	CID000001170
Drug	AC1NA07U	NCL FBLL1 FBL HNRNPR	1.06e-05	95	33	4	CID004369512
Drug	NPLA	NANOS3 NCL FBL	1.76e-05	35	33	3	CID000004387
Drug	2gg8	NCL FBLL1 FBL	2.08e-05	37	33	3	CID006914647
Drug	poly(G	CIRBP NCL FUS FMR1	2.18e-05	114	33	4	CID000439502
Drug	uranium	U2AF1 NCL FBLL1 GAR1 FBL	2.94e-05	252	33	5	CID000023989
Drug	ovothiol A	NCL FBLL1 FBL	3.53e-05	44	33	3	CID000130131
Drug	AC1Q6T4Q	FBLL1 MBD2 FBL	3.78e-05	45	33	3	CID000000516
Drug	AC1L8WBM	NANOS3 FMR1 MBD2 FXR2	4.23e-05	135	33	4	CID000388647
Drug	U1 3	FBLL1 GAR1 FBL	5.19e-05	50	33	3	CID011840989
Drug	reverse T	NCL GAR1 FBL	8.11e-05	58	33	3	CID000064973
Drug	AC1NRA5C	TRA2A U2AF1 FUS HNRNPR	1.13e-04	174	33	4	CID005287709
Drug	pyranine	FBLL1 FBL	1.33e-04	12	33	2	CID000061388
Drug	AC1L1DSW	FBLL1 GAR1 FBL	1.42e-04	70	33	3	CID000002493
Drug	arabinosyluracil	U2AF1 NCL GAR1 FBL HNRNPR	1.47e-04	354	33	5	CID000001177
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	HNRNPA0 KMT2B UBAP2L AHDC1	1.69e-04	193	33	4	6931_DN
Drug	AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A	LSM14A TAF15 NFATC2IP FXR2	1.69e-04	193	33	4	6920_UP
Drug	Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A	LARP1 FAM98A KMT2B UBAP2L	1.72e-04	194	33	4	1547_DN
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A	LARP1 LSM14A TAF15 UBAP2L	1.76e-04	195	33	4	1296_DN
Drug	Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A	TAF15 FUS FXR2 UBAP2L	1.83e-04	197	33	4	4966_DN
Drug	rofecoxib; Down 200; 10uM; MCF7; HG-U133A	FMR1 NFATC2IP MBD2 UBAP2L	1.86e-04	198	33	4	166_DN
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A	LARP1 LSM14A TAF15 FXR2	1.90e-04	199	33	4	2083_DN
Drug	naphthalene acetic acid	TRA2A NCL FBL	1.96e-04	78	33	3	CID000006862
Disease	malignant pleural mesothelioma (implicated_via_orthology)	FMR1 FXR2	3.64e-06	3	33	2	DOID:7474 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis type 6 (implicated_via_orthology)	TAF15 FUS	3.64e-06	3	33	2	DOID:0060198 (implicated_via_orthology)
Disease	fragile X syndrome (implicated_via_orthology)	FMR1 FXR2	3.64e-06	3	33	2	DOID:14261 (implicated_via_orthology)
Disease	Amyotrophic Lateral Sclerosis	DPP6 TAF15 FUS	3.77e-05	58	33	3	C0002736
Disease	frontotemporal dementia (implicated_via_orthology)	TAF15 FUS	7.95e-05	12	33	2	DOID:9255 (implicated_via_orthology)
Disease	HIV Coinfection	U2AF1 ALYREF ILF2	2.09e-04	103	33	3	C4505456
Disease	HIV Infections	U2AF1 ALYREF ILF2	2.09e-04	103	33	3	C0019693
Disease	Ovarian Failure, Premature	NANOS3 FMR1	2.51e-04	21	33	2	C0085215
Disease	Amyotrophic Lateral Sclerosis With Dementia	DPP6 FUS	4.83e-04	29	33	2	C0393554
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	TAF15 FUS	5.17e-04	30	33	2	DOID:332 (implicated_via_orthology)
Disease	Amyotrophic Lateral Sclerosis, Guam Form	DPP6 FUS	5.53e-04	31	33	2	C0543859
Disease	amyotrophic lateral sclerosis (is_implicated_in)	DPP6 FUS	5.89e-04	32	33	2	DOID:332 (is_implicated_in)
Disease	internet addiction disorder	AVEN FMR1	6.27e-04	33	33	2	EFO_0803368
Disease	Adenocarcinoma of lung (disorder)	NCL GAR1 FBL	1.57e-03	206	33	3	C0152013
Disease	obsolete_red blood cell distribution width	LARP1 LSM14A KMT2B RBM27 FXR2 PAIP1	3.43e-03	1347	33	6	EFO_0005192
Disease	Autism Spectrum Disorders	CIRBP DPP6	4.09e-03	85	33	2	C1510586

Protein segments in the cluster

Peptide	Gene	Start	Entry
GRGRGGRGRGSRGRG	BRWD3	1686	Q6RI45
GRGRGSRGRGGGGTR	BRWD3	1691	Q6RI45
SRGRGGGGTRGRGRG	BRWD3	1696	Q6RI45
GGGTRGRGRGRGGRG	BRWD3	1701	Q6RI45
RRRGGKAGGFGGRGG	AHDC1	666	Q5TGY3
RRGGGGGAGFRGAGK	NANOS3	146	P60323
RGGGSGGGRRGRGGY	TAF15	326	Q92804
GGGRRGRGGYRGRGG	TAF15	331	Q92804
GRGGYRGRGGFQGRG	TAF15	336	Q92804
RGRGGRGGDRGGYGG	TAF15	406	Q92804
RGGDRGGYGGDRSGG	TAF15	411	Q92804
GGDRGGYGGDRSRGG	TAF15	516	Q92804
GRGRGRGRGGRGRGS	RBM27	951	Q9P2N5
DLGRPGRGGRGGRGG	SERBP1	361	Q8NC51
GRGGRGGRGGRGRGG	SERBP1	366	Q8NC51
GGRGGRGRGGRPNRG	SERBP1	371	Q8NC51
GRGRGRGRGRGRGGT	LARP1	341	Q6PKG0
GGSYGGRGRGRRTGG	FXR2	426	P51116
QDRGGRGRGGSGGGG	FUS	211	P35637
NRGGGNGRGGRGRGG	FUS	376	P35637
GRGGDRGGFRGGRGG	FUS	486	P35637
RGGFRGGRGGGDRGG	FUS	491	P35637
GARARGFGGGGRGRG	FBLL1	51	A6NHQ2
GFGGGGRGRGRGGGD	FBLL1	56	A6NHQ2
GRGRGRGGGDGKDRG	FBLL1	61	A6NHQ2
GFGGRGGFGDRGGRG	FBL	11	P22087
GGFGDRGGRGGRGGF	FBL	16	P22087
RGGRGGRGGFGGGRG	FBL	21	P22087
GGGRGRGGGFRGRGR	FBL	31	P22087
RGGGFRGRGRGGGGG	FBL	36	P22087
GYAVRGRGGGRGGRG	HNRNPR	496	O43390
RGGYRGRGGLGFRGG	LSM14A	406	Q8ND56
GRGGLGFRGGRGRGG	LSM14A	411	Q8ND56
GFRGGRGRGGGRGGT	LSM14A	416	Q8ND56
GFRGGFRGGRGGREF	LSM14A	436	Q8ND56
SRGGRGGRGRGRGGG	KMT2B	286	Q9UMN6
RGGGRGGFGGRGGGR	NCL	656	P19338
RGGGRGGRGGFGGRG	NCL	666	P19338
RGGFGGRGGFRGGRG	NCL	681	P19338
AGRGRSRGLGRGGGG	PAIP1	11	Q9H074
GGVCGRGRGRGRGRG	MBD2	71	Q9UBB5
GRRRGGGGRGQGGRG	FMR1	531	Q06787
GGGGGDGGGRRGRGR	AVEN	41	Q9NQS1
GRGFRGARGGRGGGG	AVEN	56	Q9NQS1
RGGGAGGRGRRGRGR	CCDC9	121	Q9Y3X0
GRGRGGRFGSRGGPG	ILF2	6	Q12905
RGGGGGGAGGRPRFQ	DPP6	56	P42658
FRGGGRGGFGRGGGR	GAR1	41	Q9NY12
GGRGGRGGGRGGGGR	GAR1	171	Q9NY12
RGGGRGGGGRGGGRG	GAR1	176	Q9NY12
GGGFRGGRGGGFRGR	GAR1	201	Q9NY12
DRGGGRGGRGGRGGR	FAM98A	456	Q8NCA5
RGGRGGRGGRGGRAG	FAM98A	461	Q8NCA5
GAGRGGRGGWGGRGR	NFATC2IP	16	Q8NCF5
GRGRGGFGGRGRGRG	CHTOP	186	Q9Y3Y2
GFGGRGRGRGRGRGA	CHTOP	191	Q9Y3Y2
GGRGRGRGFSRGGGD	CIRBP	106	Q14011
GRGFSRGGGDRGYGG	CIRBP	111	Q14011
GRGRGRGGSGRRGGR	UBAP2L	176	Q14157
SRGGRGGRGRGGGRD	HNRNPA0	191	Q13151
GGGGGGGGGGGRRRD	TRA2A	221	Q13595
SRDRGRGGGGGGGGG	U2AF1	206	Q01081
GGGGGGGGRERDRRR	U2AF1	216	Q01081
RGGGGGGPRLRGGER	PLEKHG2	321	Q9H7P9
GGRGGGRGRGRAGSQ	ALYREF	21	Q86V81
GRGRGRAGSQGGRGG	ALYREF	26	Q86V81
GGGGTRRGTRGGARG	ALYREF	211	Q86V81